26
|
Han J, Wang QJ, Wang CH, Li ZH, Bai RH, Zhang X, Liu JG. [A study of the correlation between gray matter atrophy in multiple sclerosis and impairment of cognitive function domains]. ZHONGHUA NEI KE ZA ZHI 2024; 63:666-673. [PMID: 38951090 DOI: 10.3760/cma.j.cn112138-20231129-00350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 07/03/2024]
Abstract
Objective: To quantify cerebral cortical and deep gray matter atrophy in patients with multiple sclerosis (MS) and explore its correlation with impairment in domains of cognitive function. Methods: Twenty patients with MS and 16 healthy controls (HC) matched for age, sex, and education level were included. Using FreeSurfer software, based on 3D-MRI technology, the differences in cortical thickness and deep gray matter volume between the two groups were comparatively analyzed. A neuropsychological scale that included six domains of cognitive function was scored on both study groups to analyze the correlation between cortical thickness and volume of deep gray matter in MS patients with impairment in cognitive function domains. Results: Impairment in domains of cognitive function: cognitive impairment was present in 60% MS patients in this study, mainly manifesting as impairment of verbal memory, verbal fluency, visuospatial memory, and information processing speed function (all P<0.05). Of these, the majority had impaired visuospatial memory function (55.0%), and the least number of patients had impaired information processing speed (15.0%). Changes in cortical thickness: compared with the HC group, the MS group showed that cortical atrophy was mainly concentrated in the frontoparietal region, including significant thinning of cortical thickness in the left inferior parietal gyrus, right superior frontal gyrus, and the right superior parietal gyrus (all P<0.05). Among them, atrophy of the left inferior parietal gyrus was significantly positively correlated with the impairment of verbal memory, verbal fluency, and information processing speed (all P<0.05). There was a significant positive correlation between the right superior frontal gyrus atrophy and verbal memory, verbal fluency, and visuospatial memory impairment (all P<0.05). Changes in deep gray matter volume: compared with the HC group, deep gray matter volume in the MS group decreased significantly in the bilateral thalamus, bilateral putamen, bilateral pallidum (all P<0.01), and right nucleus accumbens (P<0.05). Among them, left thalamus atrophy was significantly positively correlated with visuospatial memory impairment (r=0.45, P=0.046), and left putamen atrophy was both significantly positively correlated with visuospatial memory (r=0.45, P=0.047) and information processing speed impairment (r=0.50, P=0.026). Conclusions: Early structural brain changes in MS are dominated by gray matter atrophy. Deep gray matter is more prominent than cortical atrophy.
Collapse
|
27
|
Szczepanski JM, Lieberman JA, Lamps LW, Gonzalez RS, Xue Y, Zhang X, Yilmaz OH, Hart J, Krausz T, Mantilla JG, McHugh JB, Westerhoff M. Histologic Features of Mycobacterial Spindle Cell Pseudotumors: A Multi-institutional Clinicopathologic Analysis of 14 Cases. Am J Surg Pathol 2024; 48:890-900. [PMID: 38726848 DOI: 10.1097/pas.0000000000002234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/21/2024]
Abstract
Mycobacterial spindle cell pseudotumors (MSPs) are a rare and diagnostically challenging manifestation of non-tuberculous mycobacterial (NTM) infections. Proper recognition of these pseudotumors is important because they are treatable and benign. In this study, we evaluated the morphologic patterns of MSPs to improve their pathologic identification. Clinical and morphologic features of 14 MSPs were analyzed. Histologic factors evaluated included the architectural growth pattern of spindled or epithelioid macrophages, granulomas and their location within the lesion, neutrophilic microabscesses, multinucleated giant cells, necrosis, and effacement of background tissue. The composition of inflammatory infiltrates, organism density by acid-fast staining, and stromal changes were also assessed. In addition, 8 of 14 cases underwent molecular microbiology identification by a clinical amplicon-sequencing assay for non-tuberculous mycobacteria. MSP sites included 2 bowel, 10 lymph nodes, 1 liver, and 1 extremity. Cases with available clinical history (n=10) all occurred in immunocompromised patients. All demonstrated effacement of normal structures with spindled cells arranged in a storiform or fascicular architectural pattern. In addition, all cases showed lymphocytic inflammation, with prominent concurrent neutrophilic inflammation in 50% (7/14) of cases. Other morphologic findings included foamy histiocytes (64%, 9/14), peripherally situated granulomas (21%, 3/14), and neutrophilic microabscesses (21%, 3/14). All tested cases were positive for NTM by PCR methods. Mycobacterium avium was the most commonly isolated pathogen (6/8). Mycobacterial spindle cell pseudotumors show predominantly spindled morphology that may be mistaken as a neoplasm. Surgical pathologists who evaluate lymph nodes, soft tissue, and gastrointestinal tissues should be aware of this spindled tumefactive phenomenon in the setting of immunocompromised patients. Recognition of key morphologic features of neutrophilic inflammation, peripheral granulomas, or foamy histiocytes within a spindled lesion can help guide the pathologist to a correct diagnosis of an inflammatory process secondary to infection rather than a spindle cell neoplasm. Accurate diagnosis to facilitate appropriate antimicrobial and/or surgical therapy requires a comprehensive evaluation combining clinical, histopathologic, and microbiological findings.
Collapse
|
28
|
Bao J, Zhang X, Xiang S, Liu H, Cheng M, Yang Y, Huang X, Xiang W, Cui W, Lai HC, Huang S, Wang Y, Qian D, Yu H. Deep Learning-Based Facial and Skeletal Transformations for Surgical Planning. J Dent Res 2024; 103:809-819. [PMID: 38808566 DOI: 10.1177/00220345241253186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2024] Open
Abstract
The increasing application of virtual surgical planning (VSP) in orthognathic surgery implies a critical need for accurate prediction of facial and skeletal shapes. The craniofacial relationship in patients with dentofacial deformities is still not understood, and transformations between facial and skeletal shapes remain a challenging task due to intricate anatomical structures and nonlinear relationships between the facial soft tissue and bones. In this study, a novel bidirectional 3-dimensional (3D) deep learning framework, named P2P-ConvGC, was developed and validated based on a large-scale data set for accurate subject-specific transformations between facial and skeletal shapes. Specifically, the 2-stage point-sampling strategy was used to generate multiple nonoverlapping point subsets to represent high-resolution facial and skeletal shapes. Facial and skeletal point subsets were separately input into the prediction system to predict the corresponding skeletal and facial point subsets via the skeletal prediction subnetwork and facial prediction subnetwork. For quantitative evaluation, the accuracy was calculated with shape errors and landmark errors between the predicted skeleton or face with corresponding ground truths. The shape error was calculated by comparing the predicted point sets with the ground truths, with P2P-ConvGC outperforming existing state-of-the-art algorithms including P2P-Net, P2P-ASNL, and P2P-Conv. The total landmark errors (Euclidean distances of craniomaxillofacial landmarks) of P2P-ConvGC in the upper skull, mandible, and facial soft tissues were 1.964 ± 0.904 mm, 2.398 ± 1.174 mm, and 2.226 ± 0.774 mm, respectively. Furthermore, the clinical feasibility of the bidirectional model was validated using a clinical cohort. The result demonstrated its prediction ability with average surface deviation errors of 0.895 ± 0.175 mm for facial prediction and 0.906 ± 0.082 mm for skeletal prediction. To conclude, our proposed model achieved good performance on the subject-specific prediction of facial and skeletal shapes and showed clinical application potential in postoperative facial prediction and VSP for orthognathic surgery.
Collapse
|
29
|
Zhu F, Liu N, Zhang X, Zhou L. Withdrawal reaction from Janus kinase inhibitor manifesting as hepatitis B virus outbreak: a case report. Scand J Rheumatol 2024:1-3. [PMID: 38916127 DOI: 10.1080/03009742.2024.2363101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2023] [Accepted: 05/30/2024] [Indexed: 06/26/2024]
|
30
|
Chen L, Wu T, Zhang M, Ding Z, Zhang Y, Yang Y, Zheng J, Zhang X. [Identification of potential biomarkers and immunoregulatory mechanisms of rheumatoid arthritis based on multichip co-analysis of GEO database]. NAN FANG YI KE DA XUE XUE BAO = JOURNAL OF SOUTHERN MEDICAL UNIVERSITY 2024; 44:1098-1108. [PMID: 38977339 PMCID: PMC11237296 DOI: 10.12122/j.issn.1673-4254.2024.06.10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 07/10/2024]
Abstract
OBJECTIVE To identify the biomarkers for early rheumatoid arthritis (RA) diagnosis and explore the possible immune regulatory mechanisms. METHODS The differentially expressed genesin RA were screened and functionally annotated using the limma, RRA, batch correction, and clusterProfiler. The protein-protein interaction network was retrieved from the STRING database, and Cytoscape 3.8.0 and GeneMANIA were used to select the key genes and predicting their interaction mechanisms. ROC curves was used to validate the accuracy of diagnostic models based on the key genes. The disease-specific immune cells were selected via machine learning, and their correlation with the key genes were analyzed using Corrplot package. Biological functions of the key genes were explored using GSEA method. The expression of STAT1 was investigated in the synovial tissue of rats with collagen-induced arthritis (CIA). RESULTS We identified 9 core key genes in RA (CD3G, CD8A, SYK, LCK, IL2RG, STAT1, CCR5, ITGB2, and ITGAL), which regulate synovial inflammation primarily through cytokines-related pathways. ROC curve analysis showed a high predictive accuracy of the 9 core genes, among which STAT1 had the highest AUC (0.909). Correlation analysis revealed strong correlations of CD3G, ITGAL, LCK, CD8A, and STAT1 with disease-specific immune cells, and STAT1 showed the strongest correlation with M1-type macrophages (R=0.68, P=2.9e-08). The synovial tissues of the ankle joints of CIA rats showed high expressions of STAT1 and p-STAT1 with significant differential expression of STAT1 between the nucleus and the cytoplasm of the synovial fibroblasts. The protein expressions of p-STAT1 and STAT1 in the cell nuclei were significantly reduced after treatment. CONCLUSION CD3G, CD8A, SYK, LCK, IL2RG, STAT1, CCR5, ITGB2, and ITGAL may serve as biomarkers for early diagnosis of RA. Gene-immune cell pathways such as CD3G/CD8A/LCK-γδ T cells, ITGAL-Tfh cells, and STAT1-M1-type macrophages may be closely related with the development of RA.
Collapse
|
31
|
Li L, Wang M, Liu S, Zhang X, Chen J, Tao W, Li S, Qing Z, Tao Q, Liu Y, Huang L, Zhao S. [Soy isoflavones alleviates calcium overload in rats with cerebral ischemia-reperfusion by inhibiting the Wnt/Ca 2+ signaling pathway]. NAN FANG YI KE DA XUE XUE BAO = JOURNAL OF SOUTHERN MEDICAL UNIVERSITY 2024; 44:1048-1058. [PMID: 38977334 PMCID: PMC11237289 DOI: 10.12122/j.issn.1673-4254.2024.06.05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 07/10/2024]
Abstract
OBJECTIVE To explore the mechanism by which soybean isoflavone (SI) reduces calcium overload induced by cerebral ischemia-reperfusion (I/R). METHODS Forty-eight SD rats were randomized into 4 groups to receive sham operation, cerebral middle artery occlusion for 2 h followed by 24 h of reperfusion (I/R model group), or injection of adeno-associated virus carrying Frizzled-2 siRNA or empty viral vector into the lateral cerebral ventricle after modeling.Western blotting was used to examine Frizzled-2 knockdown efficiency and changes in protein expressions in the Wnt/Ca2+ signaling pathway.Calcium levels and pathological changes in the ischemic penumbra (IP) were measured using calcium chromogenic assay and HE staining, respectively.Another 72 SD randomly allocated for sham operation, I/R modeling, or soy isoflavones pretreatment before modeling were examined for regional cerebral blood flow using a Doppler flowmeter, and the cerebral infarct volume was assessed using TTC staining.Pathologies in the IP area were evaluated using HE and Nissl staining, and ROS level, Ca2+ level, cell apoptosis, and intracellular calcium concentration were analyzed using immunofluorescence assay or flow cytometry; the protein expressions of Wnt5a, Frizzled-2, and P-CaMK Ⅱ in the IP were detected with Western blotting and immunohistochemistry. RESULTS In rats with cerebral I/R, Frizzled-2 knockdown significantly lowered calcium concentration (P < 0.001) and the expression levels of Wnt5a, Frizzled-2, and P-CaMK Ⅱ in the IP area.In soy isoflavones-pretreated rats, calcium concentration, ROS and MDA levels, cell apoptosis rate, cerebral infarct volume, and expression levels of Wnt/Ca2+ signaling pathway-related proteins were all significantly lower while SOD level was higher than those in rats in I/R model group. CONCLUSION Soy isoflavones can mitigate calcium overload in rats with cerebral I/R by inhibiting the Wnt/Ca2+ signaling pathway.
Collapse
|
32
|
Zhang X, Zhang H, Hou F, Fang T, Zhang C, Wang H, Song S, Lan H, Wang Y, Hou H. Neoadjuvant PD-(L)1 blockade plus platinum-based chemotherapy for potentially resectable oncogene-positive non-small cell lung cancer. World J Surg Oncol 2024; 22:159. [PMID: 38890622 PMCID: PMC11184808 DOI: 10.1186/s12957-024-03434-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2024] [Accepted: 06/01/2024] [Indexed: 06/20/2024] Open
Abstract
BACKGROUND Whether programmed cell death-1/ligand-1 (PD-1/PD-L1) blockade-based neoadjuvant treatment may benefit locally advanced oncogene-mutant non-small cell lung cancer (NSCLC) patients remains controversial. This retrospective study was designed to observe the efficacy and safety of neoadjuvant PD-1/PD-L1 blockade plus chemotherapy versus chemotherapy and corresponding tyrosine kinase inhibitors (TKIs) in patients with resectable oncogene-positive NSCLC. METHODS Patients with potential resectable NSCLC harbouring oncogene alterations who had received neoadjuvant treatment were retrospectively recruited, and an oncogene-negative cohort of patients who received neoadjuvant PD-(L)1 blockade-based neoadjuvant treatment was reviewed for comparison during the same period. The primary aim was to observe the treatment efficacy and event-free survival (EFS) of these agents. Safety profile, molecular target, and immunologic factor data, including PD-L1 expression and tumour mutational burden (TMB), were also obtained. RESULTS A total of 46 patients were recruited. Thirty-one of them harboured oncogene alterations, including EGFR, KRAS, ERBB2, ROS1, MET, RET, ALK, and FGFR3 alterations. Among the oncogene-positive patients, 18 patients received neoadjuvant PD-(L)1 blockade immunotherapy plus chemotherapy (oncogene-positive IO group), 13 patients were treated with neoadjuvant chemotherapy and/or corresponding TKIs or TKIs alone (oncogene-positive chemo/TKIs group), and the other 15 patients were oncogene negative and received neoadjuvant PD-(L)1 blockade plus chemotherapy (oncogene-negative IO group). The pathological complete response (pCR) and major pathological response (MPR) rates were 22.2% (4 of 18) and 44.4% (8 of 18) in the oncogene-positive IO group, 0% (P = 0.120) and 23.1% (3 of 13) (P = 0.276) in the oncogene-positive chemo/TKIs group, and 46.7% (7 of 15) (P = 0.163) and 80.0% (12 of 15) (P = 0.072) in the oncogene-negative IO group, respectively. By the last follow-up, the median EFS time had not reached in the oncogene-positive IO group, and was 29.5 months in the oncogene-positive chemo/TKIs group and 38.4 months in the oncogene-negative IO group. CONCLUSION Compared with chemotherapy/TKIs treatment, neoadjuvant treatment with PD-(L)1 blockade plus platinum-based chemotherapy was associated with higher pCR/MPR rates in patients with partially resectable oncogene-mutant NSCLC, while the pCR/MPR rates were lower than their oncogene-negative counterparts treated with PD-(L)1 blockade-based treatment. Specifically, oncogene alteration types and other predictors of response to immunotherapy should be taken into account in clinical practice.
Collapse
|
33
|
Shi J, Ji R, Guan Z, Zhang X, Lu Y. [Effect of oxymatrine on Cryptosporidium parvum infection in mice based on the HMGB1-TLR2/TLR4-NF-κB pathway]. ZHONGGUO XUE XI CHONG BING FANG ZHI ZA ZHI = CHINESE JOURNAL OF SCHISTOSOMIASIS CONTROL 2024; 36:286-293. [PMID: 38952315 DOI: 10.16250/j.32.1374.2024019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 07/03/2024]
Abstract
OBJECTIVE To investigate the involvement of the high mobility group box protein B1 (HMGB1)-Toll-like receptor 2 (TLR2)/TLR4-nuclear factor κB (NF-κB) pathway in the intestinal mucosal injury induced by Cryptosporidium parvum infection, and to examine the effect of oxymatrine (OMT) on C. parvum infection in mice. METHODS Forty SPF 4-week-old BALB/c mice were randomly divided into four groups, including the control group, infection group, glycyrrhizin (GA) group and OMT group. Each mouse was orally administered with 1 × 105 C. parvum oocysts one week in the infection, GA and OMT groups following dexamethasone-induced immunosuppression to model C. parvum intestinal infections in mice. Upon successful modeling, mice in the GA group were intraperitoneally injected with GA at a daily dose of 25.9 mL/kg for successive two weeks, and animals in the OMT group were orally administered OMT at a daily dose of 50 mg/kg for successive two weeks, while mice in the control group were given normal food and water. All mice were sacrificed two weeks post-treatment, and proximal jejunal tissues were sampled. The pathological changes of mouse intestinal mucosal specimens were observed using hematoxylin-eosin (HE) staining, and the mouse intestinal villous height, intestinal crypt depth and the ratio of intestinal villous height to intestinal crypt depth were measured. The occludin and zonula occludens protein 1 (ZO1) expression was determined in mouse intestinal epithelial cells using immunohistochemistry, and the relative expression of HMGB1, TLR2, TLR4, myeloid differentiation primary response gene 88 (MyD88) and NF-κB p65 mRNA was quantified in mouse jejunal tissues using quantitative real-time PCR (qPCR) assay. RESULTS HE staining showed that the mouse intestinal villi were obviously atrophic, shortened, and detached, and the submucosal layer of the mouse intestine was edematous in the infection group as compared with the control group, while the mouse intestinal villi tended to be structurally intact and neatly arranged in the GA and OMT groups. There were significant differences among the four groups in terms of the mouse intestinal villous height (F = 6.207, P = 0.000 5), intestinal crypt depth (F = 6.903, P = 0.000 3) and the ratio of intestinal villous height to intestinal crypt depth (F = 37.190, P < 0.000 1). The mouse intestinal villous height was lower in the infection group than in the control group [(321.9 ± 41.1) μm vs. (399.5 ± 30.9) μm; t = 4.178, P < 0.01] and the GA group [(321.9 ± 41.1) μm vs. (383.7 ± 42.7) μm; t = 3.130, P < 0.01], and the mouse intestinal crypt depth was greater in the infection group [(185.0 ± 35.9) μm] than in the control group [(128.4 ± 23.6) μm] (t = 3.877, P < 0.01) and GA group [(143.3 ± 24.7) μm] (t = 2.710, P < 0.05). The mouse intestinal villous height was greater in the OMT group [(375.3 ± 22.9) μm] than in the infection group (t = 3.888, P < 0.01), and there was no significant difference in mouse intestinal villous height between the OMT group and the control group (t = 1.989, P > 0.05). The mouse intestinal crypt depth was significantly lower in the OMT group [(121.5 ± 27.3) μm] than in the infection group (t = 4.133, P < 0.01), and there was no significant difference in mouse intestinal crypt depth between the OMT group and the control group (t = 0.575, P > 0.05). The ratio of the mouse intestinal villous height to intestinal crypt depth was significantly lower in the infection group (1.8 ± 0.2) than in the control group (3.1 ± 0.3) (t = 10.540, P < 0.01) and the GA group (2.7 ± 0.3) (t = 7.370, P < 0.01), and the ratio of the mouse intestinal villous height to intestinal crypt depth was significantly higher in the OMT group (3.1 ± 0.2) than in the infection group (t = 15.020, P < 0.01); however, there was no significant difference in the ratio of the mouse intestinal villous height to intestinal crypt depth between the OMT group and the control group (t = 0.404, P > 0.05). Immunohistochemical staining showed significant differences among the four groups in terms of occludin (F = 28.031, P < 0.000 1) and ZO1 expression (F = 14.122, P < 0.000 1) in mouse intestinal epithelial cells. The proportion of positive occluding expression was significantly lower in mouse intestinal epithelial cells in the infection group than in the control group [(14.3 ± 4.5)% vs. (28.3 ± 0.5)%; t = 3.810, P < 0.01], and the proportions of positive occluding expression were significantly higher in mouse intestinal epithelial cells in the GA group [(30.3 ± 1.3)%] and OMT group [(25.8 ± 1.5)%] than in the infection group (t = 7.620 and 5.391, both P values < 0.01); however, there was no significant differences in the proportion of positive occluding expression in mouse intestinal epithelial cells between the GA or OMT groups and the control group (t = 1.791 and 2.033, both P values > 0.05). The proportion of positive ZO1 expression was significantly lower in mouse intestinal epithelial cells in the infection group than in the control group [(14.4 ± 1.8)% vs. (24.2 ± 2.8)%; t = 4.485, P < 0.01], and the proportions of positive ZO1 expression were significantly higher in mouse intestinal epithelial cells in the GA group [(24.1 ± 2.3)%] (t = 5.159, P < 0.01) and OMT group than in the infection group [(22.5 ± 1.9)%] (t = 4.441, P < 0.05); however, there were no significant differences in the proportion of positive ZO1 expression in mouse intestinal epithelial cells between the GA or OMT groups and the control group (t = 0.037 and 0.742, both P values > 0.05). qPCR assay showed significant differences among the four groups in terms of HMGB1 (F = 21.980, P < 0.000 1), TLR2 (F = 20.630, P < 0.000 1), TLR4 (F = 17.000, P = 0.000 6), MyD88 (F = 8.907, P = 0.000 5) and NF-κB p65 mRNA expression in mouse jejunal tissues (F = 8.889, P = 0.000 7). The relative expression of HMGB1 [(5.97 ± 1.07) vs. (1.05 ± 0.07); t = 6.482, P < 0.05] 、TLR2 [(5.92 ± 1.29) vs. (1.10 ± 0.14); t = 5.272, P < 0.05] 、TLR4 [(5.96 ± 1.50) vs. (1.02 ± 0.03); t = 4.644, P < 0.05] 、MyD88 [(3.00 ± 1.26) vs. (1.02 ± 0.05); t = 2.734, P < 0.05] and NF-κB p65 mRNA [(2.33 ± 0.72) vs. (1.04 ± 0.06); t = 2.665, P < 0.05] was all significantly higher in mouse jejunal tissues in the infection group than in the control group. A significant reduction was detected in the relative expression of HMGB1 (0.63 ± 0.01), TLR2 (0.42 ± 0.10), TLR4 (0.35 ± 0.07), MyD88 (0.70 ± 0.11) and NF-κB p65 mRNA (0.75 ± 0.01) in mouse jejunal tissues in the GA group relative to the control group (t = 8.629, 5.830, 11.500, 4.729 and 6.898, all P values < 0.05), and the relative expression of HMGB1, TLR2, TLR4, MyD88 and NF-κB p65 mRNA significantly reduced in mouse jejunal tissues in the GA group as compared to the infection group (t = 7.052, 6.035, 4.084, 3.165 and 3.274, all P values < 0.05). In addition, the relative expression of HMGB1 (1.14 ± 0.60), TLR2 (1.00 ± 0.24), TLR4 (1.14 ± 0.07), MyD88 (0.96 ± 0.25) and NF-κ B p65 mRNA (1.12 ± 0.17) was significantly lower in mouse jejunal tissues in the OMT group than in the infection group (t = 7.059, 5.320, 3.510, 3.466 and 3.273, all P values < 0.05); however, there were no significant differences between the OMT and control groups in terms of relative expression of HMGB1, TLR2, TLR4, MyD88 or NF-κB p65 mRNA in mouse jejunal tissues (t = 0.239, 0.518, 1.887, 0.427 and 0.641, all P values > 0.05). CONCLUSIONS C. parvum infection causes intestinal inflammatory responses and destruction of intestinal mucosal barrier through up-regulating of the HMGB1-TLR2/TLR4-NF-κB pathway. OMT may suppress the intestinal inflammation and repair the intestinal mucosal barrier through inhibiting the activity of the HMGB1-TLR2/TLR4-NF-κB pathway.
Collapse
|
34
|
Hu S, Graham RP, Choi WT, Wen KW, Putra J, Chen W, Lin J, Gonzalez IA, Panarelli N, Liu Q, Zhao L, Gong S, Mejia-Bautista M, Escobar DJ, Ma C, Shalaby A, Du X, Kang LI, Zhang W, Chen X, Ding X, Chen HH, Ye Z, Pezhouh MK, Liao X, Liu Y, Yang Z, Alpert L, Hart J, Goldblum JR, Allende D, Zheng W, Gonzalez RS, Wang HL, Zhang X, Liu X, Longacre T, Westerhoff M, Xue Y. Clinicopathologic Features of Gastrointestinal Tract Langerhans Cell Histiocytosis. Mod Pathol 2024; 37:100543. [PMID: 38897453 DOI: 10.1016/j.modpat.2024.100543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2024] [Revised: 05/21/2024] [Accepted: 06/11/2024] [Indexed: 06/21/2024]
Abstract
Gastrointestinal (GI) tract involvement by Langerhans cell histiocytosis (LCH) is rare and its clinicopathologic characteristics have only been described in case reports and small series. We reviewed hematoxylin and eosin and CD1a, S100, and Langerin immunohistochemical-stained slides from 47 patients with well-documented demographic and clinical findings. Our cases included 8 children and 39 adults, with a mean follow-up of 63 months. All pediatric patients had concurrent multisystem LCH, presented with GI symptoms, and showed nonpolypoid lesions. Seven (88%) showed multifocal GI disease, including 5 with multiple GI organ involvement. All sampled lesions from children exhibited infiltrative growth. More than half had died of the disease or manifested persistent LCH at last follow-up. Twenty-five of 39 (64%) adults had LCH involving only the GI tract (single system), with the remaining 14 (36%) exhibiting multisystem disease. Adult single-system GI LCH was typically encountered incidentally on screening/surveillance endoscopy (72%). Most exhibited isolated colorectal involvement (88%) as a solitary polyp (92%), with a well-demarcated/noninfiltrative growth pattern (70%), and excellent prognosis (100%). In comparison, adult patients with multisystem LCH more frequently presented with GI symptoms (92%, P < .001), noncolorectal GI site involvement (50%, P = .02), multifocal GI lesions (43%, P = .005), nonpolypoid lesions (71%, P < .001), infiltrative histologic growth pattern (78%, P = .04), and persistent disease (57%, P < .001). Adult patients with multisystem LCH appear to exhibit similar clinicopathologic features to those of pediatric patients. These results demonstrated that adults with single-system LCH involving the GI tract have an excellent prognosis, whereas multisystem LCH occurring at any age carries an unfavorable prognosis. High-risk features of GI LCH include pediatric age, GI symptomatology, noncolorectal GI involvement, multifocal GI disease, nonpolypoid lesions, and infiltrative growth pattern.
Collapse
|
35
|
Zhang X, Kim JB, Antypas D. Coherent amplitude modulation of continuous-wave light in cesium vapor. OPTICS LETTERS 2024; 49:3348-3351. [PMID: 38875617 DOI: 10.1364/ol.522219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/26/2024] [Accepted: 05/24/2024] [Indexed: 06/16/2024]
Abstract
We report on observations of coherent, sustained oscillations in the absorption of continuous-wave light at 388 nm that excites the 6S1/2 → 8P3/2 transition in cesium (Cs) vapor. The oscillation frequency is close to the spacing of hyperfine levels of the 8P3/2 level that are excited simultaneously by the 388 nm field. We observe a threshold behavior of the oscillation amplitude with pump power and suggest that the effect is associated with infrared directional emission due to amplified spontaneous emission (ASE) from the 8P3/2 → 8S1/2 transition that is assisted by retro-reflections from cell windows. The effect may be used to probe a lasing process in an atomic vapor, by checking the temporal properties of the pump field transmitted through the vapor.
Collapse
|
36
|
Zhu X, Peng C, Wu Z, Zhang X, Liu S, Luo Y, Yang L. Establishment of a rabbit model of different degrees of testicular torsion. Actas Urol Esp 2024:S2173-5786(24)00077-5. [PMID: 38885741 DOI: 10.1016/j.acuroe.2024.05.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2024] [Revised: 04/26/2024] [Accepted: 04/29/2024] [Indexed: 06/20/2024]
Abstract
INTRODUCTION AND OBJECTIVES Different degrees of testicular torsion result in varying degrees of testicular damage, which influences treatment options and outcomes. Therefore, establishing a testicular torsion model with different degrees is necessary for clinical diagnosis. MATERIALS AND METHODS Rabbits were randomly divided into four groups and their spermatic cords were twisted at 0 °, 180 °, 360 °, and 720 °, respectively. Color Doppler flow imaging (CDFI) were performed to evaluate the blood supply in testicles. The twisted testicles were surgically removed at six hours post-operation and were evaluated by morphological observation and Hematoxylin and Eosin staining. RESULTS CDFI signals were gradually decreased as the degree of testicular torsion increased, and scores of CDFI in the 360 ° and 720 ° groups were significantly decreased at postoperative six hours compared to pre-surgery. Compared to the sham, the testicle in the 180 ° group exhibited slight congestion, whereas the testicles in the 360 ° and 720 ° groups were dark red in color and had severe congestion and unrecognizable vessels. Hematoxylin and Eosin staining showed mild spermatogenic cell reduction and testicular interstitial hemorrhage in the 180 ° group. In the 360 ° and 720 ° groups, disordered seminiferous tubules, shed spermatogenic cells in tubules, inflammatory cell infiltration, and severe hemorrhage were found. In comparison with the sham, interstitial hemorrhage scores in the 360 ° and 720 ° groups were significantly higher, and scores of germinal epithelial cell thickness in the three testicular torsion groups were significantly decreased. CONCLUSIONS Collectively, we successfully constructed a testicular torsion model with different degrees in rabbits.
Collapse
|
37
|
Ke YL, Pan L, Lyu J, Sun DJY, Pei P, Chen YP, Yang L, Du HD, Clarke R, Chen JS, Chen ZM, Zhang X, Chen T, Li RQ, Qi LT, Li LM, Yu CQ. [Distribution and influencing factors of lipoprotein (a) levels in non-arteriosclerotic cardiovascular disease population in China]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2024; 45:779-786. [PMID: 38889976 DOI: 10.3760/cma.j.cn112338-20240105-00004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/20/2024]
Abstract
Objective: To describe the distribution of lipoprotein (a) [Lp(a)] levels in non-arteriosclerotic cardiovascular disease (ASCVD) population in China and explore its influencing factors. Methods: This study was based on a nested case-control study in the CKB study measured plasma biomarkers. Lp(a) levels was measured using a polyclonal antibody-based turbidimetric assay certified by the reference laboratory and ≥75.0 nmol/L defined as high Lp(a). Multiple logistic regression model was used to examine the factors related to Lp(a) levels. Results: Among the 5 870 non-ASCVD population included in the analysis, Lp(a) levels showed a right-skewed distribution, with a M (Q1, Q3) of 17.5 (8.8, 43.5) nmol/L. The multiple logistic regression analysis found that female was associated with high Lp(a) (OR=1.23, 95%CI: 1.05-1.43). The risk of increased Lp(a) levels in subjects with abdominal obesity was significantly reduced (OR=0.68, 95%CI: 0.52-0.89). As TC, LDL-C, apolipoprotein A1(Apo A1), and apolipoprotein B(Apo B) levels increased, the risk of high Lp(a) increased, with OR (95%CI) for each elevated group was 2.40 (1.76-3.24), 2.68 (1.36-4.93), 1.29 (1.03-1.61), and 1.65 (1.27-2.13), respectively. The risk of high Lp(a) was reduced in the HDL-C lowering group with an OR (95%CI) of 0.76 (0.61-0.94). In contrast, an increase in TG levels and the ratio of Apo A1/Apo B(Apo A1/B) was negatively correlated with the risk of high Lp(a), with OR (95%CI) of 0.73 (0.60-0.89) for elevated triglyceride group, and OR (95%CI) of 0.60 (0.50-0.72) for the Apo A1/B ratio increase group (linear trend test P≤0.001 except for Apo A1). However, no correlation was found between Lp(a) levels and lifestyle factors such as diet, smoking, and physical activity. Conclusions: Lp(a) levels were associated with sex and abdominal obesity, but less with lifestyle behaviors.
Collapse
|
38
|
Guo RP, Yang LY, Du J, Zhao JF, Shi F, Zhang X, Su J. [Copy number variations of CCND1 gene and chromosome 11 centromere in acral melanoma]. ZHONGHUA BING LI XUE ZA ZHI = CHINESE JOURNAL OF PATHOLOGY 2024; 53:557-562. [PMID: 38825900 DOI: 10.3760/cma.j.cn112151-20231015-00264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/04/2024]
Abstract
Objective: To study the correlation between the copy number variations of CCND1 gene and chromosome 11 and their associations with clinicopathologic features in acral melanoma. Methods: Thirty-three acral melanoma cases diagnosed at the Department of Pathology of Peking University Third Hospital, Beijing, China from January 2018 to August 2021 were collected. Fluorescence in situ hybridization (FISH) was used to detect the copy number of CCND1 gene and centromere of chromosome 11. The relationship between the copy numbers of CCND1 and chromosome 11 centromere, and the correlation between CCND1 copy number and clinicopathologic characteristics were analyzed. Results: There were 15 male and 18 female patients, with an age ranging from 22-86 years. 63.6% (21/33) of the patients had an increased CCND1 gene copy number. 21.2% (7/33) of patients with increased CCND1 copy number had an accompanying chromosome 11 centromere copy number increase. 27.3% (9/33) of the cases had a low copy number of CCND1 gene, and 4 of them (4/33, 12.1%) were accompanied by chromosome 11 centromere copy number increase. 36.4% (12/33) of the cases had a high copy number of CCND1 gene, and 3 (3/33, 9.1%) of them were accompanied by chromosome 11 centromere copy number increase. No cases with CCND1 low copy number increase showed CCND1/CEP11 ratio greater than 2.00. The 11 cases with CCND1 high copy number increase showed CCND1/CEP11 ratio greater than or equal to 2.00. However, there was no significant correlation between CCND1 copy number increase and any of the examined clinicopathologic features such as age, sex, histological type, Breslow thickness, ulcer and Clark level. Conclusions: CCND1 copy number increase is a significant molecular alteration in acral melanoma. In some cases, CCND1 copy number increase may be accompanied by the copy number increase of chromosome 11. For these cases the copy number increase in CCND1 gene may be a result of the copy number change of chromosome 11.
Collapse
|
39
|
Aad G, Aakvaag E, Abbott B, Abeling K, Abicht NJ, Abidi SH, Aboulhorma A, Abramowicz H, Abreu H, Abulaiti Y, Acharya BS, Adam Bourdarios C, Adamczyk L, Addepalli SV, Addison MJ, Adelman J, Adiguzel A, Adye T, Affolder AA, Afik Y, Agaras MN, Agarwala J, Aggarwal A, Agheorghiesei C, Ahmad A, Ahmadov F, Ahmed WS, Ahuja S, Ai X, Aielli G, Aikot A, Ait Tamlihat M, Aitbenchikh B, Aizenberg I, Akbiyik M, Åkesson TPA, Akimov AV, Akiyama D, Akolkar NN, Aktas S, Al Khoury K, Alberghi GL, Albert J, Albicocco P, Albouy GL, Alderweireldt S, Alegria ZL, Aleksa M, Aleksandrov IN, Alexa C, Alexopoulos T, Alfonsi F, Algren M, Alhroob M, Ali B, Ali HMJ, Ali S, Alibocus SW, Aliev M, Alimonti G, Alkakhi W, Allaire C, Allbrooke BMM, Allen JF, Allendes Flores CA, Allport PP, Aloisio A, Alonso F, Alpigiani C, Alvarez Estevez M, Alvarez Fernandez A, Alves Cardoso M, Alviggi MG, Aly M, Amaral Coutinho Y, Ambler A, Amelung C, Amerl M, Ames CG, Amidei D, Amirie KJ, Amor Dos Santos SP, Amos KR, Ananiev V, Anastopoulos C, Andeen T, Anders JK, Andrean SY, Andreazza A, Angelidakis S, Angerami A, Anisenkov AV, Annovi A, Antel C, Anthony MT, Antipov E, Antonelli M, Anulli F, Aoki M, Aoki T, Aparisi Pozo JA, Aparo MA, Aperio Bella L, Appelt C, Apyan A, Arbiol Val SJ, Arcangeletti C, Arce ATH, Arena E, Arguin JF, Argyropoulos S, Arling JH, Arnaez O, Arnold H, Artoni G, Asada H, Asai K, Asai S, Asbah NA, Assamagan K, Astalos R, Atashi S, Atkin RJ, Atkinson M, Atmani H, Atmasiddha PA, Augsten K, Auricchio S, Auriol AD, Austrup VA, Avolio G, Axiotis K, Azuelos G, Babal D, Bachacou H, Bachas K, Bachiu A, Backman F, Badea A, Baer TM, Bagnaia P, Bahmani M, Bahner D, Bai K, Bailey AJ, Bailey VR, Baines JT, Baines L, Baker OK, Bakos E, Bakshi Gupta D, Balakrishnan V, Balasubramanian R, Baldin EM, Balek P, Ballabene E, Balli F, Baltes LM, Balunas WK, Balz J, Banas E, Bandieramonte M, Bandyopadhyay A, Bansal S, Barak L, Barakat M, Barberio EL, Barberis D, Barbero M, Barel MZ, Barends KN, Barillari T, Barisits MS, Barklow T, Baron P, Baron Moreno DA, Baroncelli A, Barone G, Barr AJ, Barr JD, Barreiro F, Barreiro Guimarães da Costa J, Barron U, Barros Teixeira MG, Barsov S, Bartels F, Bartoldus R, Barton AE, Bartos P, Basan A, Baselga M, Bassalat A, Basso MJ, Basson CR, Bates RL, Batlamous S, Batool B, Battaglia M, Battulga D, Bauce M, Bauer M, Bauer P, Bazzano Hurrell LT, Beacham JB, Beau T, Beaucamp JY, Beauchemin PH, Bechtle P, Beck HP, Becker K, Beddall AJ, Bednyakov VA, Bee CP, Beemster LJ, Beermann TA, Begalli M, Begel M, Behera A, Behr JK, Beirer JF, Beisiegel F, Belfkir M, Bella G, Bellagamba L, Bellerive A, Bellos P, Beloborodov K, Benchekroun D, Bendebba F, Benhammou Y, Benkendorfer KC, Beresford L, Beretta M, Bergeaas Kuutmann E, Berger N, Bergmann B, Beringer J, Bernardi G, Bernius C, Bernlochner FU, Bernon F, Berrocal Guardia A, Berry T, Berta P, Berthold A, Bethke S, Betti A, Bevan AJ, Bhalla NK, Bhamjee M, Bhatta S, Bhattacharya DS, Bhattarai P, Bhide KD, Bhopatkar VS, Bianchi RM, Bianco G, Biebel O, Bielski R, Biglietti M, Billingsley CS, Bindi M, Bingul A, Bini C, Biondini A, Birch-Sykes CJ, Bird GA, Birman M, Biros M, Biryukov S, Bisanz T, Bisceglie E, Biswal JP, Biswas D, Bjørke K, Bloch I, Blue A, Blumenschein U, Blumenthal J, Bobrovnikov VS, Boehler M, Boehm B, Bogavac D, Bogdanchikov AG, Bohm C, Boisvert V, Bokan P, Bold T, Bomben M, Bona M, Boonekamp M, Booth CD, Borbély AG, Bordulev IS, Borecka-Bielska HM, Borissov G, Bortoletto D, Boscherini D, Bosman M, Bossio Sola JD, Bouaouda K, Bouchhar N, Boudreau J, Bouhova-Thacker EV, Boumediene D, Bouquet R, Boveia A, Boyd J, Boye D, Boyko IR, Bracinik J, Brahimi N, Brandt G, Brandt O, Braren F, Brau B, Brau JE, Brener R, Brenner L, Brenner R, Bressler S, Britton D, Britzger D, Brock I, Brooijmans G, Brost E, Brown LM, Bruce LE, Bruckler TL, Bruckman de Renstrom PA, Brüers B, Bruni A, Bruni G, Bruschi M, Bruscino N, Buanes T, Buat Q, Buchin D, Buckley AG, Bulekov O, Bullard BA, Burdin S, Burgard CD, Burger AM, Burghgrave B, Burlayenko O, Burr JTP, Burton CD, Burzynski JC, Busch EL, Büscher V, Bussey PJ, Butler JM, Buttar CM, Butterworth JM, Buttinger W, Buxo Vazquez CJ, Buzykaev AR, Cabrera Urbán S, Cadamuro L, Caforio D, Cai H, Cai Y, Cai Y, Cairo VMM, Cakir O, Calace N, Calafiura P, Calderini G, Calfayan P, Callea G, Caloba LP, Calvet D, Calvet S, Calvetti M, Camacho Toro R, Camarda S, Camarero Munoz D, Camarri P, Camerlingo MT, Cameron D, Camincher C, Campanelli M, Camplani A, Canale V, Canbay AC, Cantero J, Cao Y, Capocasa F, Capua M, Carbone A, Cardarelli R, Cardenas JCJ, Cardillo F, Carducci G, Carli T, Carlino G, Carlotto JI, Carlson BT, Carlson EM, Carminati L, Carnelli A, Carnesale M, Caron S, Carquin E, Carrá S, Carratta G, Carroll AM, Carter TM, Casado MP, Caspar M, Castillo FL, Castillo Garcia L, Castillo Gimenez V, Castro NF, Catinaccio A, Catmore JR, Cavaliere T, Cavaliere V, Cavalli N, Cekmecelioglu YC, Celebi E, Celli F, Centonze MS, Cepaitis V, Cerny K, Cerqueira AS, Cerri A, Cerrito L, Cerutti F, Cervato B, Cervelli A, Cesarini G, Cetin SA, Chakraborty D, Chan J, Chan WY, Chapman JD, Chapon E, Chargeishvili B, Charlton DG, Chatterjee M, Chauhan C, Che Y, Chekanov S, Chekulaev SV, Chelkov GA, Chen A, Chen B, Chen B, Chen H, Chen H, Chen J, Chen J, Chen M, Chen S, Chen SJ, Chen X, Chen X, Chen Y, Cheng CL, Cheng HC, Cheong S, Cheplakov A, Cheremushkina E, Cherepanova E, Cherkaoui El Moursli R, Cheu E, Cheung K, Chevalier L, Chiarella V, Chiarelli G, Chiedde N, Chiodini G, Chisholm AS, Chitan A, Chitishvili M, Chizhov MV, Choi K, Chou Y, Chow EYS, Chu KL, Chu MC, Chu X, Chudoba J, Chwastowski JJ, Cieri D, Ciesla KM, Cindro V, Ciocio A, Cirotto F, Citron ZH, Citterio M, Ciubotaru DA, Clark A, Clark PJ, Clarry C, Clavijo Columbie JM, Clawson SE, Clement C, Clercx J, Coadou Y, Cobal M, Coccaro A, Barrue RFC, Coelho Lopes De Sa R, Coelli S, Cole B, Collot J, Conde Muiño P, Connell MP, Connell SH, Conroy EI, Conventi F, Cooke HG, Cooper-Sarkar AM, Cordeiro Oudot Choi A, Corpe LD, Corradi M, Corriveau F, Cortes-Gonzalez A, Costa MJ, Costanza F, Costanzo D, Cote BM, Cowan G, Cranmer K, Cremonini D, Crépé-Renaudin S, Crescioli F, Cristinziani M, Cristoforetti M, Croft V, Crosby JE, Crosetti G, Cueto A, Cuhadar Donszelmann T, Cui H, Cui Z, Cunningham WR, Curcio F, Czodrowski P, Czurylo MM, De Sousa MJDCS, Da Fonseca Pinto JV, Da Via C, Dabrowski W, Dado T, Dahbi S, Dai T, Dal Santo D, Dallapiccola C, Dam M, D'amen G, D'Amico V, Damp J, Dandoy JR, Danninger M, Dao V, Darbo G, Darmora S, Das SJ, D'Auria S, D'avanzo A, David C, Davidek T, Davis-Purcell B, Dawson I, Day-Hall HA, De K, De Asmundis R, De Biase N, De Castro S, De Groot N, de Jong P, De la Torre H, De Maria A, De Salvo A, De Sanctis U, De Santis F, De Santo A, De Vivie De Regie JB, Dedovich DV, Degens J, Deiana AM, Del Corso F, Del Peso J, Del Rio F, Delagrange L, Deliot F, Delitzsch CM, Della Pietra M, Della Volpe D, Dell'Acqua A, Dell'Asta L, Delmastro M, Delsart PA, Demers S, Demichev M, Denisov SP, D'Eramo L, Derendarz D, Derue F, Dervan P, Desch K, Deutsch C, Di Bello FA, Di Ciaccio A, Di Ciaccio L, Di Domenico A, Di Donato C, Di Girolamo A, Di Gregorio G, Di Luca A, Di Micco B, Di Nardo R, Diamantopoulou M, Dias FA, Vale TDD, Diaz MA, Diaz Capriles FG, Didenko M, Diehl EB, Díez Cornell S, Diez Pardos C, Dimitriadi C, Dimitrievska A, Dingfelder J, Dinu IM, Dittmeier SJ, Dittus F, Djama F, Djobava T, Doglioni C, Dohnalova A, Dolejsi J, Dolezal Z, Dona KM, Donadelli M, Dong B, Donini J, D'Onofrio A, D'Onofrio M, Dopke J, Doria A, Dos Santos Fernandes N, Dougan P, Dova MT, Doyle AT, Draguet MA, Dreyer E, Drivas-Koulouris I, Drnevich M, Drozdova M, Du D, du Pree TA, Dubinin F, Dubovsky M, Duchovni E, Duckeck G, Ducu OA, Duda D, Dudarev A, Duden ER, D'uffizi M, Duflot L, Dührssen M, Dumitriu AE, Dunford M, Dungs S, Dunne K, Duperrin A, Yildiz HD, Düren M, Durglishvili A, Dwyer BL, Dyckes GI, Dyndal M, Dziedzic BS, Earnshaw ZO, Eberwein GH, Eckerova B, Eggebrecht S, Purcino De Souza EE, Ehrke LF, Eigen G, Einsweiler K, Ekelof T, Ekman PA, El Farkh S, El Ghazali Y, El Jarrari H, El Moussaouy A, Ellajosyula V, Ellert M, Ellinghaus F, Ellis N, Elmsheuser J, Elsing M, Emeliyanov D, Enari Y, Ene I, Epari S, Erland PA, Errenst M, Escalier M, Escobar C, Etzion E, Evans G, Evans H, Evans LS, Ezhilov A, Ezzarqtouni S, Fabbri F, Fabbri L, Facini G, Fadeyev V, Fakhrutdinov RM, Fakoudis D, Falciano S, Falda Ulhoa Coelho LF, Falke PJ, Faltova J, Fan C, Fan Y, Fang Y, Fanti M, Faraj M, Farazpay Z, Farbin A, Farilla A, Farooque T, Farrington SM, Fassi F, Fassouliotis D, Faucci Giannelli M, Fawcett WJ, Fayard L, Federic P, Federicova P, Fedin OL, Feickert M, Feligioni L, Fellers DE, Feng C, Feng M, Feng Z, Fenton MJ, Ferencz L, Ferguson RAM, Fernandez Luengo SI, Fernandez Martinez P, Fernoux MJV, Ferrando J, Ferrari A, Ferrari P, Ferrari R, Ferrere D, Ferretti C, Fiedler F, Fiedler P, Filipčič A, Filmer EK, Filthaut F, Fiolhais MCN, Fiorini L, Fisher WC, Fitschen T, Fitzhugh PM, Fleck I, Fleischmann P, Flick T, Flores M, Flores Castillo LR, Flores Sanz De Acedo L, Follega FM, Fomin N, Foo JH, Formica A, Forti AC, Fortin E, Fortman AW, Foti MG, Fountas L, Fournier D, Fox H, Francavilla P, Francescato S, Franchellucci S, Franchini M, Franchino S, Francis D, Franco L, Franco Lima V, Franconi L, Franklin M, Frattari G, Freund WS, Frid YY, Friend J, Fritzsche N, Froch A, Froidevaux D, Frost JA, Fu Y, Fuenzalida Garrido S, Fujimoto M, Fung KY, De Simas Filho EF, Furukawa M, Fuster J, Gabrielli A, Gabrielli A, Gadow P, Gagliardi G, Gagnon LG, Galantzan S, Gallas EJ, Gallop BJ, Gan KK, Ganguly S, Gao Y, Garay Walls FM, Garcia B, García C, Garcia Alonso A, Garcia Caffaro AG, García Navarro JE, Garcia-Sciveres M, Gardner GL, Gardner RW, Garelli N, Garg D, Garg RB, Gargan JM, Garner CA, Garvey CM, Gaspar P, Gassmann VK, Gaudio G, Gautam V, Gauzzi P, Gavrilenko IL, Gavrilyuk A, Gay C, Gaycken G, Gazis EN, Geanta AA, Gee CM, Gekow A, Gemme C, Genest MH, Gentry AD, George S, George WF, Geralis T, Gessinger-Befurt P, Geyik ME, Ghani M, Ghneimat M, Ghorbanian K, Ghosal A, Ghosh A, Ghosh A, Giacobbe B, Giagu S, Giani T, Giannetti P, Giannini A, Gibson SM, Gignac M, Gil DT, Gilbert AK, Gilbert BJ, Gillberg D, Gilles G, Ginabat L, Gingrich DM, Giordani MP, Giraud PF, Giugliarelli G, Giugni D, Giuli F, Gkialas I, Gladilin LK, Glasman C, Gledhill GR, Glemža G, Glisic M, Gnesi I, Go Y, Goblirsch-Kolb M, Gocke B, Godin D, Gokturk B, Goldfarb S, Golling T, Gololo MGD, Golubkov D, Gombas JP, Gomes A, Gomes Da Silva G, Gomez Delegido AJ, Gonçalo R, Gonella L, Gongadze A, Gonnella F, Gonski JL, González Andana RY, González de la Hoz S, Gonzalez Lopez R, Gonzalez Renteria C, Gonzalez Rodrigues MV, Gonzalez Suarez R, Gonzalez-Sevilla S, Gonzalvo Rodriguez GR, Goossens L, Gorini B, Gorini E, Gorišek A, Gosart TC, Goshaw AT, Gostkin MI, Goswami S, Gottardo CA, Gotz SA, Gouighri M, Goumarre V, Goussiou AG, Govender N, Grabowska-Bold I, Graham K, Gramstad E, Grancagnolo S, Grant CM, Gravila PM, Gravili FG, Gray HM, Greco M, Grefe C, Gregor IM, Grenier P, Grewe SG, Grillo AA, Grimm K, Grinstein S, Grivaz JF, Gross E, Grosse-Knetter J, Grundy JC, Guan L, Gubbels C, Guerrero Rojas JGR, Guerrieri G, Guescini F, Gugel R, Guhit JAM, Guida A, Guilloton E, Guindon S, Guo F, Guo J, Guo L, Guo Y, Gupta R, Gupta R, Gurbuz S, Gurdasani SS, Gustavino G, Guth M, Gutierrez P, Gutierrez Zagazeta LF, Gutsche M, Gutschow C, Gwenlan C, Gwilliam CB, Haaland ES, Haas A, Habedank M, Haber C, Hadavand HK, Hadef A, Hadzic S, Hagan AI, Hahn JJ, Haines EH, Haleem M, Haley J, Hall JJ, Hallewell GD, Halser L, Hamano K, Hamer M, Hamity GN, Hampshire EJ, Han J, Han K, Han L, Han L, Han S, Han YF, Hanagaki K, Hance M, Hangal DA, Hanif H, Hank MD, Hansen JB, Hansen PH, Hara K, Harada D, Harenberg T, Harkusha S, Harris ML, Harris YT, Harrison J, Harrison NM, Harrison PF, Hartman NM, Hartmann NM, Hasegawa Y, Hauser R, Hawkes CM, Hawkings RJ, Hayashi Y, Hayashida S, Hayden D, Hayes C, Hayes RL, Hays CP, Hays JM, Hayward HS, He F, He M, He Y, He Y, He Y, Heatley NB, Hedberg V, Heggelund AL, Hehir ND, Heidegger C, Heidegger KK, Heidorn WD, Heilman J, Heim S, Heim T, Heinlein JG, Heinrich JJ, Heinrich L, Hejbal J, Held A, Hellesund S, Helling CM, Hellman S, Henderson RCW, Henkelmann L, Henriques Correia AM, Herde H, Hernández Jiménez Y, Herrmann LM, Herrmann T, Herten G, Hertenberger R, Hervas L, Hesping ME, Hessey NP, Hill E, Hillier SJ, Hinds JR, Hinterkeuser F, Hirose M, Hirose S, Hirschbuehl D, Hitchings TG, Hiti B, Hobbs J, Hobincu R, Hod N, Hodgkinson MC, Hodkinson BH, Hoecker A, Hofer DD, Hofer J, Holm T, Holzbock M, Hommels LBAH, Honan BP, Hong J, Hong TM, Hooberman BH, Hopkins WH, Horii Y, Hou S, Howard AS, Howarth J, Hoya J, Hrabovsky M, Hrynevich A, Hryn'ova T, Hsu PJ, Hsu SC, Hu Q, Huang S, Huang X, Huang X, Huang Y, Huang Y, Huang Z, Hubacek Z, Huebner M, Huegging F, Huffman TB, Hugli CA, Huhtinen M, Huiberts SK, Hulsken R, Huseynov N, Huston J, Huth J, Hyneman R, Iacobucci G, Iakovidis G, Ibragimov I, Iconomidou-Fayard L, Iddon JP, Iengo P, Iguchi R, Iizawa T, Ikegami Y, Ilic N, Imam H, Ince Lezki M, Ingebretsen Carlson T, Introzzi G, Iodice M, Ippolito V, Irwin RK, Ishino M, Islam W, Issever C, Istin S, Ito H, Iuppa R, Ivina A, Izen JM, Izzo V, Jacka P, Jackson P, Jaeger BP, Jagfeld CS, Jain G, Jain P, Jakobs K, Jakoubek T, Jamieson J, Janas KW, Javurkova M, Jeanty L, Jejelava J, Jenni P, Jessiman CE, Jia C, Jia J, Jia X, Jia X, Jia Z, Jiggins S, Jimenez Pena J, Jin S, Jinaru A, Jinnouchi O, Johansson P, Johns KA, Johnson JW, Jones DM, Jones E, Jones P, Jones RWL, Jones TJ, Joos HL, Joshi R, Jovicevic J, Ju X, Junggeburth JJ, Junkermann T, Juste Rozas A, Juzek MK, Kabana S, Kaczmarska A, Kado M, Kagan H, Kagan M, Kahn A, Kahn A, Kahra C, Kaji T, Kajomovitz E, Kakati N, Kalaitzidou I, Kalderon CW, Kang NJ, Kar D, Karava K, Kareem MJ, Karentzos E, Karkanias I, Karkout O, Karpov SN, Karpova ZM, Kartvelishvili V, Karyukhin AN, Kasimi E, Katzy J, Kaur S, Kawade K, Kawale MP, Kawamoto C, Kawamoto T, Kay EF, Kaya FI, Kazakos S, Kazanin VF, Ke Y, Keaveney JM, Keeler R, Kehris GV, Keller JS, Kelly AS, Kempster JJ, Kennedy PD, Kepka O, Kerridge BP, Kersten S, Kerševan BP, Keshri S, Keszeghova L, Ketabchi Haghighat S, Khan RA, Khanov A, Kharlamov AG, Kharlamova T, Khoda EE, Kholodenko M, Khoo TJ, Khoriauli G, Khubua J, Khwaira YAR, Kibirige B, Kilgallon A, Kim DW, Kim YK, Kimura N, Kingston MK, Kirchhoff A, Kirfel C, Kirfel F, Kirk J, Kiryunin AE, Kitsaki C, Kivernyk O, Klassen M, Klein C, Klein L, Klein MH, Klein SB, Klein U, Klimek P, Klimentov A, Klioutchnikova T, Kluit P, Kluth S, Kneringer E, Knight TM, Knue A, Kobayashi R, Kobylianskii D, Koch SF, Kocian M, Kodyš P, Koeck DM, Koenig PT, Koffas T, Kolay O, Koletsou I, Komarek T, Köneke K, Kong AXY, Kono T, Konstantinidis N, Kontaxakis P, Konya B, Kopeliansky R, Koperny S, Korcyl K, Kordas K, Korn A, Korn S, Korolkov I, Korotkova N, Kortman B, Kortner O, Kortner S, Kostecka WH, Kostyukhin VV, Kotsokechagia A, Kotwal A, Koulouris A, Kourkoumeli-Charalampidi A, Kourkoumelis C, Kourlitis E, Kovanda O, Kowalewski R, Kozanecki W, Kozhin AS, Kramarenko VA, Kramberger G, Kramer P, Krasny MW, Krasznahorkay A, Kraus JW, Kremer JA, Kresse T, Kretzschmar J, Kreul K, Krieger P, Krishnamurthy S, Krivos M, Krizka K, Kroeninger K, Kroha H, Kroll J, Kroll J, Krowpman KS, Kruchonak U, Krüger H, Krumnack N, Kruse MC, Kuchinskaia O, Kuday S, Kuehn S, Kuesters R, Kuhl T, Kukhtin V, Kulchitsky Y, Kuleshov S, Kumar M, Kumari N, Kumari P, Kupco A, Kupfer T, Kupich A, Kuprash O, Kurashige H, Kurchaninov LL, Kurdysh O, Kurochkin YA, Kurova A, Kuze M, Kvam AK, Kvita J, Kwan T, Kyriacou NG, Laatu LAO, Lacasta C, Lacava F, Lacker H, Lacour D, Lad NN, Ladygin E, Laforge B, Lagouri T, Lahbabi FZ, Lai S, Lakomiec IK, Lalloue N, Lambert JE, Lammers S, Lampl W, Lampoudis C, Lamprinoudis G, Lancaster AN, Lançon E, Landgraf U, Landon MPJ, Lang VS, Langrekken OKB, Lankford AJ, Lanni F, Lantzsch K, Lanza A, Lapertosa A, Laporte JF, Lari T, Lasagni Manghi F, Lassnig M, Latonova V, Laudrain A, Laurier A, Lawlor SD, Lawrence Z, Lazaridou R, Lazzaroni M, Le B, Le Boulicaut EM, Leban B, Lebedev A, LeBlanc M, Ledroit-Guillon F, Lee ACA, Lee SC, Lee S, Lee TF, Leeuw LL, Lefebvre HP, Lefebvre M, Leggett C, Lehmann Miotto G, Leigh M, Leight WA, Leinonen W, Leisos A, Leite MAL, Leitgeb CE, Leitner R, Leney KJC, Lenz T, Leone S, Leonidopoulos C, Leopold A, Leroy C, Les R, Lester CG, Levchenko M, Levêque J, Levinson LJ, Levrini G, Lewicki MP, Lewis DJ, Li A, Li B, Li C, Li CQ, Li H, Li H, Li H, Li H, Li H, Li J, Li K, Li L, Li M, Li QY, Li S, Li S, Li T, Li X, Li Z, Li Z, Li Z, Liang S, Liang Z, Liberatore M, Liberti B, Lie K, Lieber Marin J, Lien H, Lin K, Lindley RE, Lindon JH, Lipeles E, Lipniacka A, Lister A, Little JD, Liu B, Liu BX, Liu D, Liu JB, Liu JKK, Liu K, Liu M, Liu MY, Liu P, Liu Q, Liu X, Liu X, Liu Y, Liu YL, Liu YW, Llorente Merino J, Lloyd SL, Lobodzinska EM, Loch P, Lohse T, Lohwasser K, Loiacono E, Lokajicek M, Lomas JD, Long JD, Longarini I, Longo L, Longo R, Lopez Paz I, Lopez Solis A, Lorenzo Martinez N, Lory AM, Löschcke Centeno G, Loseva O, Lou X, Lou X, Lounis A, Love PA, Lu G, Lu M, Lu S, Lu YJ, Lubatti HJ, Luci C, Lucio Alves FL, Luehring F, Luise I, Lukianchuk O, Lundberg O, Lund-Jensen B, Luongo NA, Lutz MS, Lux AB, Lynn D, Lysak R, Lytken E, Lyubushkin V, Lyubushkina T, Lyukova MM, Ma H, Ma K, Ma LL, Ma W, Ma Y, Mac Donell DM, Maccarrone G, MacDonald JC, Machado De Abreu Farias PC, Madar R, Mader WF, Madula T, Maeda J, Maeno T, Maguire H, Maiboroda V, Maio A, Maj K, Majersky O, Majewski S, Makovec N, Maksimovic V, Malaescu B, Malecki P, Maleev VP, Malek F, Mali M, Malito D, Mallik U, Maltezos S, Malyukov S, Mamuzic J, Mancini G, Mancini MN, Manco G, Mandalia JP, Mandić I, Manhaes de Andrade Filho L, Maniatis IM, Manjarres Ramos J, Mankad DC, Mann A, Manzoni S, Mao L, Mapekula X, Marantis A, Marchiori G, Marcisovsky M, Marcon C, Marinescu M, Marium S, Marjanovic M, Markovitch M, Marshall EJ, Marshall Z, Marti-Garcia S, Martin TA, Martin VJ, Martin Dit Latour B, Martinelli L, Martinez M, Martinez Agullo P, Martinez Outschoorn VI, Martinez Suarez P, Martin-Haugh S, Martoiu VS, Martyniuk AC, Marzin A, Mascione D, Masetti L, Mashimo T, Masik J, Maslennikov AL, Massarotti P, Mastrandrea P, Mastroberardino A, Masubuchi T, Mathisen T, Matousek J, Matsuzawa N, Maurer J, Maček B, Maximov DA, Mazini R, Maznas I, Mazza M, Mazza SM, Mazzeo E, Mc Ginn C, Mc Gowan JP, Mc Kee SP, McCracken CC, McDonald EF, McDougall AE, Mcfayden JA, McGovern RP, Mchedlidze G, Mckenzie RP, Mclachlan TC, Mclaughlin DJ, McMahon SJ, Mcpartland CM, McPherson RA, Mehlhase S, Mehta A, Melini D, Mellado Garcia BR, Melo AH, Meloni F, Mendes Jacques Da Costa AM, Meng HY, Meng L, Menke S, Mentink M, Meoni E, Mercado G, Merlassino C, Merola L, Meroni C, Metcalfe J, Mete AS, Meyer C, Meyer JP, Middleton RP, Mijović L, Mikenberg G, Mikestikova M, Mikuž M, Mildner H, Milic A, Miller DW, Miller EH, Miller LS, Milov A, Milstead DA, Min T, Minaenko AA, Minashvili IA, Mince L, Mincer AI, Mindur B, Mineev M, Mino Y, Mir LM, Miralles Lopez M, Mironova M, Mishima A, Missio MC, Mitra A, Mitsou VA, Mitsumori Y, Miu O, Miyagawa PS, Mkrtchyan T, Mlinarevic M, Mlinarevic T, Mlynarikova M, Mobius S, Mogg P, Mohamed Farook MH, Mohammed AF, Mohapatra S, Mokgatitswane G, Moleri L, Mondal B, Mondal S, Mönig K, Monnier E, Monsonis Romero L, Montejo Berlingen J, Montella M, Montereali F, Monticelli F, Monzani S, Morange N, De Carvalho ALM, Moreno Llácer M, Moreno Martinez C, Morettini P, Morgenstern S, Morii M, Morinaga M, Morodei F, Morvaj L, Moschovakos P, Moser B, Mosidze M, Moskalets T, Moskvitina P, Moss J, Moussa A, Moyse EJW, Mtintsilana O, Muanza S, Mueller J, Muenstermann D, Müller R, Mullier GA, Mullin AJ, Mullin JJ, Mungo DP, Munoz Perez D, Munoz Sanchez FJ, Murin M, Murray WJ, Muškinja M, Mwewa C, Myagkov AG, Myers AJ, Myers G, Myska M, Nachman BP, Nackenhorst O, Nagai K, Nagano K, Nagle JL, Nagy E, Nairz AM, Nakahama Y, Nakamura K, Nakkalil K, Nanjo H, Narayan R, Narayanan EA, Naryshkin I, Naseri M, Nasri S, Nass C, Navarro G, Navarro-Gonzalez J, Nayak R, Nayaz A, Nechaeva PY, Nechansky F, Nedic L, Neep TJ, Negri A, Negrini M, Nellist C, Nelson C, Nelson K, Nemecek S, Nessi M, Neubauer MS, Neuhaus F, Neundorf J, Newhouse R, Newman PR, Ng CW, Ng YWY, Ngair B, Nguyen HDN, Nickerson RB, Nicolaidou R, Nielsen J, Niemeyer M, Niermann J, Nikiforou N, Nikolaenko V, Nikolic-Audit I, Nikolopoulos K, Nilsson P, Ninca I, Nindhito HR, Ninio G, Nisati A, Nishu N, Nisius R, Nitschke JE, Nkadimeng EK, Nobe T, Noel DL, Nommensen T, Norfolk MB, Norisam RRB, Norman BJ, Noury M, Novak J, Novak T, Novotny L, Novotny R, Nozka L, Ntekas K, Nunes De Moura Junior NMJ, Ocariz J, Ochi A, Ochoa I, Oerdek S, Offermann JT, Ogrodnik A, Oh A, Ohm CC, Oide H, Oishi R, Ojeda ML, Okumura Y, Seabra LFO, Olivares Pino SA, Oliveira Damazio D, Oliveira Goncalves D, Oliver JL, Öncel ÖO, O'Neill AP, Onofre A, Onyisi PUE, Oreglia MJ, Orellana GE, Orestano D, Orlando N, Orr RS, O'Shea V, Osojnak LM, Ospanov R, Otero Y Garzon G, Otono H, Ott PS, Ottino GJ, Ouchrif M, Ould-Saada F, Owen M, Owen RE, Oyulmaz KY, Ozcan VE, Ozturk F, Ozturk N, Ozturk S, Pacey HA, Pacheco Pages A, Padilla Aranda C, Padovano G, Pagan Griso S, Palacino G, Palazzo A, Pampel J, Pan J, Pan T, Panchal DK, Pandini CE, Panduro Vazquez JG, Pandya HD, Pang H, Pani P, Panizzo G, Panwar L, Paolozzi L, Parajuli S, Paramonov A, Paraskevopoulos C, Paredes Hernandez D, Pareti A, Park KR, Park TH, Parker MA, Parodi F, Parrish EW, Parrish VA, Parsons JA, Parzefall U, Pascual Dias B, Pascual Dominguez L, Pasqualucci E, Passaggio S, Pastore F, Patel P, Patel UM, Pater JR, Pauly T, Pazos CI, Pearkes J, Pedersen M, Pedro R, Peleganchuk SV, Penc O, Pender EA, Penn GD, Penski KE, Penzin M, Peralva BS, Peixoto APP, Pereira Sanchez L, Perepelitsa DV, Perez Codina E, Perganti M, Pernegger H, Perrin O, Peters K, Peters RFY, Petersen BA, Petersen TC, Petit E, Petousis V, Petridou C, Petru T, Petrukhin A, Pettee M, Pettersson NE, Petukhov A, Petukhova K, Pezoa R, Pezzotti L, Pezzullo G, Pham TM, Pham T, Phillips PW, Piacquadio G, Pianori E, Piazza F, Piegaia R, Pietreanu D, Pilkington AD, Pinamonti M, Pinfold JL, Pereira BCP, Pinto Pinoargote AE, Pintucci L, Piper KM, Pirttikoski A, Pizzi DA, Pizzimento L, Pizzini A, Pleier MA, Plesanovs V, Pleskot V, Plotnikova E, Poddar G, Poettgen R, Poggioli L, Pokharel I, Polacek S, Polesello G, Poley A, Polini A, Pollard CS, Pollock ZB, Pompa Pacchi E, Ponomarenko D, Pontecorvo L, Popa S, Popeneciu GA, Poreba A, Portillo Quintero DM, Pospisil S, Postill MA, Postolache P, Potamianos K, Potepa PA, Potrap IN, Potter CJ, Potti H, Poulsen T, Poveda J, Pozo Astigarraga ME, Prades Ibanez A, Pretel J, Price D, Primavera M, Principe Martin MA, Privara R, Procter T, Proffitt ML, Proklova N, Prokofiev K, Proto G, Proudfoot J, Przybycien M, Przygoda WW, Psallidas A, Puddefoot JE, Pudzha D, Pyatiizbyantseva D, Qian J, Qichen D, Qin Y, Qiu T, Quadt A, Queitsch-Maitland M, Quetant G, Quinn RP, Rabanal Bolanos G, Rafanoharana D, Ragusa F, Rainbolt JL, Raine JA, Rajagopalan S, Ramakoti E, Ramirez-Berend IA, Ran K, Rapheeha NP, Rasheed H, Raskina V, Rassloff DF, Rastogi A, Rave S, Ravina B, Ravinovich I, Raymond M, Read AL, Readioff NP, Rebuzzi DM, Redlinger G, Reed AS, Reeves K, Reidelsturz JA, Reikher D, Rej A, Rembser C, Renda M, Rendel MB, Renner F, Rennie AG, Rescia AL, Resconi S, Ressegotti M, Rettie S, Reyes Rivera JG, Reynolds E, Rezanova OL, Reznicek P, Riani H, Ribaric N, Ricci E, Richter R, Richter S, Richter-Was E, Ridel M, Ridouani S, Rieck P, Riedler P, Riefel EM, Rieger JO, Rijssenbeek M, Rimoldi M, Rinaldi L, Rinn TT, Rinnagel MP, Ripellino G, Riu I, Rivera Vergara JC, Rizatdinova F, Rizvi E, Roberts BR, Robertson SH, Robinson D, Robles Gajardo CM, Robles Manzano M, Robson A, Rocchi A, Roda C, Rodriguez Bosca S, Rodriguez Garcia Y, Rodriguez Rodriguez A, Rodríguez Vera AM, Roe S, Roemer JT, Roepe-Gier AR, Roggel J, Røhne O, Rojas RA, Roland CPA, Roloff J, Romaniouk A, Romano E, Romano M, Romero Hernandez AC, Rompotis N, Roos L, Rosati S, Rosser BJ, Rossi E, Rossi E, Rossi LP, Rossini L, Rosten R, Rotaru M, Rottler B, Rougier C, Rousseau D, Rousso D, Roy A, Roy-Garand S, Rozanov A, Rozario ZMA, Rozen Y, Rubio Jimenez A, Ruby AJ, Ruelas Rivera VH, Ruggeri TA, Ruggiero A, Ruiz-Martinez A, Rummler A, Rurikova Z, Rusakovich NA, Russell HL, Russo G, Rutherfoord JP, Rutherford Colmenares S, Rybacki K, Rybar M, Rye EB, Ryzhov A, Sabater Iglesias JA, Sabatini P, Sadrozinski HFW, Safai Tehrani F, Safarzadeh Samani B, Safdari M, Saha S, Sahinsoy M, Saibel A, Saimpert M, Saito M, Saito T, Salamani D, Salnikov A, Salt J, Salvador Salas A, Salvatore D, Salvatore F, Salzburger A, Sammel D, Sampsonidis D, Sampsonidou D, Sánchez J, Sanchez Sebastian V, Sandaker H, Sander CO, Sandesara JA, Sandhoff M, Sandoval C, Sankey DPC, Sano T, Sansoni A, Santi L, Santoni C, Santos H, Santra A, Saoucha KA, Saraiva JG, Sardain J, Sasaki O, Sato K, Sauer C, Sauerburger F, Sauvan E, Savard P, Sawada R, Sawyer C, Sawyer L, Sayago Galvan I, Sbarra C, Sbrizzi A, Scanlon T, Schaarschmidt J, Schäfer U, Schaffer AC, Schaile D, Schamberger RD, Scharf C, Schefer MM, Schegelsky VA, Scheirich D, Schenck F, Schernau M, Scheulen C, Schiavi C, Schioppa M, Schlag B, Schleicher KE, Schlenker S, Schmeing J, Schmidt MA, Schmieden K, Schmitt C, Schmitt N, Schmitt S, Schoeffel L, Schoening A, Scholer PG, Schopf E, Schott M, Schovancova J, Schramm S, Schroer T, Schultz-Coulon HC, Schumacher M, Schumm BA, Schune P, Schuy AJ, Schwartz HR, Schwartzman A, Schwarz TA, Schwemling P, Schwienhorst R, Sciandra A, Sciolla G, Scuri F, Sebastiani CD, Sedlaczek K, Seema P, Seidel SC, Seiden A, Seidlitz BD, Seitz C, Seixas JM, Sekhniaidze G, Selem L, Semprini-Cesari N, Sengupta D, Senthilkumar V, Serin L, Serkin L, Sessa M, Severini H, Sforza F, Sfyrla A, Sha Q, Shabalina E, Shaheen R, Shahinian JD, Shaked Renous D, Shan LY, Shapiro M, Sharma A, Sharma AS, Sharma P, Shatalov PB, Shaw K, Shaw SM, Shcherbakova A, Shen Q, Sheppard DJ, Sherwood P, Shi L, Shi X, Shimmin CO, Shinner JD, Shipsey IPJ, Shirabe S, Shiyakova M, Shlomi J, Shochet MJ, Shojaii J, Shope DR, Shrestha B, Shrestha S, Shrif EM, Shroff MJ, Sicho P, Sickles AM, Sideras Haddad E, Sidoti A, Siegert F, Sijacki D, Sili F, Silva JM, Silva Oliveira MV, Silverstein SB, Simion S, Simoniello R, Simpson EL, Simpson H, Simpson LR, Simpson ND, Simsek S, Sindhu S, Sinervo P, Singh S, Sinha S, Sinha S, Sioli M, Siral I, Sitnikova E, Sjölin J, Skaf A, Skorda E, Skubic P, Slawinska M, Smakhtin V, Smart BH, Smirnov SY, Smirnov Y, Smirnova LN, Smirnova O, Smith AC, Smith EA, Smith HA, Smith JL, Smith R, Smizanska M, Smolek K, Snesarev AA, Snider SR, Snoek HL, Snyder S, Sobie R, Soffer A, Solans Sanchez CA, Soldatov EY, Soldevila U, Solodkov AA, Solomon S, Soloshenko A, Solovieva K, Solovyanov OV, Solovyev V, Sommer P, Sonay A, Song WY, Sopczak A, Sopio AL, Sopkova F, Sorenson JD, Sotarriva Alvarez IR, Sothilingam V, Soto Sandoval OJ, Sottocornola S, Soualah R, Soumaimi Z, South D, Soybelman N, Spagnolo S, Spalla M, Sperlich D, Spigo G, Spinali S, Spiteri DP, Spousta M, Staats EJ, Stamen R, Stampekis A, Standke M, Stanecka E, Stange MV, Stanislaus B, Stanitzki MM, Stapf B, Starchenko EA, Stark GH, Stark J, Staroba P, Starovoitov P, Stärz S, Staszewski R, Stavropoulos G, Steentoft J, Steinberg P, Stelzer B, Stelzer HJ, Stelzer-Chilton O, Stenzel H, Stevenson TJ, Stewart GA, Stewart JR, Stockton MC, Stoicea G, Stolarski M, Stonjek S, Straessner A, Strandberg J, Strandberg S, Stratmann M, Strauss M, Strebler T, Strizenec P, Ströhmer R, Strom DM, Stroynowski R, Strubig A, Stucci SA, Stugu B, Stupak J, Styles NA, Su D, Su S, Su W, Su X, Suchy D, Sugizaki K, Sulin VV, Sullivan MJ, Sultan DMS, Sultanaliyeva L, Sultansoy S, Sumida T, Sun S, Sun S, Gudnadottir OS, Sur N, Sutton MR, Suzuki H, Svatos M, Swiatlowski M, Swirski T, Sykora I, Sykora M, Sykora T, Ta D, Tackmann K, Taffard A, Tafirout R, Tafoya Vargas JS, Takubo Y, Talby M, Talyshev AA, Tam KC, Tamir NM, Tanaka A, Tanaka J, Tanaka R, Tanasini M, Tao Z, Tapia Araya S, Tapprogge S, Tarek Abouelfadl Mohamed A, Tarem S, Tariq K, Tarna G, Tartarelli GF, Tas P, Tasevsky M, Tassi E, Tate AC, Tateno G, Tayalati Y, Taylor GN, Taylor W, Tee AS, Teixeira De Lima R, Teixeira-Dias P, Teoh JJ, Terashi K, Terron J, Terzo S, Testa M, Teuscher RJ, Thaler A, Theiner O, Themistokleous N, Theveneaux-Pelzer T, Thielmann O, Thomas DW, Thomas JP, Thompson EA, Thompson PD, Thomson E, Tian Y, Tikhomirov V, Tikhonov YA, Timoshenko S, Timoshyn D, Ting EXL, Tipton P, Tlou SH, Tnourji A, Todome K, Todorova-Nova S, Todt S, Togawa M, Tojo J, Tokár S, Tokushuku K, Toldaiev O, Tombs R, Tomoto M, Tompkins L, Topolnicki KW, Torrence E, Torres H, Torró Pastor E, Toscani M, Tosciri C, Tost M, Tovey DR, Traeet A, Trandafir IS, Trefzger T, Tricoli A, Trigger IM, Trincaz-Duvoid S, Trischuk DA, Trocmé B, Truong L, Trzebinski M, Trzupek A, Tsai F, Tsai M, Tsiamis A, Tsiareshka PV, Tsigaridas S, Tsirigotis A, Tsiskaridze V, Tskhadadze EG, Tsopoulou M, Tsujikawa Y, Tsukerman II, Tsulaia V, Tsuno S, Tsuri K, Tsybychev D, Tu Y, Tudorache A, Tudorache V, Tuna AN, Turchikhin S, Turk Cakir I, Turra R, Turtuvshin T, Tuts PM, Tzamarias S, Tzanis P, Tzovara E, Ukegawa F, Ulloa Poblete PA, Umaka EN, Unal G, Unal M, Undrus A, Unel G, Urban J, Urquijo P, Urrejola P, Usai G, Ushioda R, Usman M, Uysal Z, Vacek V, Vachon B, Vadla KOH, Vafeiadis T, Vaitkus A, Valderanis C, Valdes Santurio E, Valente M, Valentinetti S, Valero A, Valiente Moreno E, Vallier A, Valls Ferrer JA, Van Arneman DR, Van Daalen TR, Van Der Graaf A, Van Gemmeren P, Van Rijnbach M, Van Stroud S, Van Vulpen I, Vanadia M, Vandelli W, Vandewall ER, Vannicola D, Vannoli L, Vari R, Varnes EW, Varni C, Varol T, Varouchas D, Varriale L, Varvell KE, Vasile ME, Vaslin L, Vasquez GA, Vasyukov A, Vavricka R, Vazeille F, Vazquez Schroeder T, Veatch J, Vecchio V, Veen MJ, Veliscek I, Veloce LM, Veloso F, Veneziano S, Ventura A, Ventura Gonzalez S, Verbytskyi A, Verducci M, Vergis C, Verissimo De Araujo M, Verkerke W, Vermeulen JC, Vernieri C, Vessella M, Vetterli MC, Vgenopoulos A, Viaux Maira N, Vickey T, Vickey Boeriu OE, Viehhauser GHA, Vigani L, Villa M, Villaplana Perez M, Villhauer EM, Vilucchi E, Vincter MG, Virdee GS, Vishwakarma A, Visibile A, Vittori C, Vivarelli I, Voevodina E, Vogel F, Voigt JC, Vokac P, Volkotrub Y, Von Ahnen J, Von Toerne E, Vormwald B, Vorobel V, Vorobev K, Vos M, Voss K, Vozak M, Vozdecky L, Vranjes N, Vranjes Milosavljevic M, Vreeswijk M, Vu NK, Vuillermet R, Vujinovic O, Vukotic I, Wada S, Wagner C, Wagner JM, Wagner W, Wahdan S, Wahlberg H, Wakida M, Walder J, Walker R, Walkowiak W, Wall A, Wallin EJ, Wamorkar T, Wang AZ, Wang C, Wang C, Wang H, Wang J, Wang RJ, Wang R, Wang R, Wang SM, Wang S, Wang T, Wang WT, Wang W, Wang X, Wang X, Wang X, Wang Y, Wang Y, Wang Z, Wang Z, Wang Z, Warburton A, Ward RJ, Warrack N, Waterhouse S, Watson AT, Watson H, Watson MF, Watton E, Watts G, Waugh BM, Weber C, Weber HA, Weber MS, Weber SM, Wei C, Wei Y, Weidberg AR, Weik EJ, Weingarten J, Weirich M, Weiser C, Wells CJ, Wenaus T, Wendland B, Wengler T, Wenke NS, Wermes N, Wessels M, Wharton AM, White AS, White A, White MJ, Whiteson D, Wickremasinghe L, Wiedenmann W, Wielers M, Wiglesworth C, Wilbern DJ, Wilkens HG, Williams DM, Williams HH, Williams S, Willocq S, Wilson BJ, Windischhofer PJ, Winkel FI, Winklmeier F, Winter BT, Winter JK, Wittgen M, Wobisch M, Wolffs Z, Wollrath J, Wolter MW, Wolters H, Woodward EL, Worm SD, Wosiek BK, Woźniak KW, Wozniewski S, Wraight K, Wu C, Wu M, Wu M, Wu SL, Wu X, Wu Y, Wu Z, Wuerzinger J, Wyatt TR, Wynne BM, Xella S, Xia L, Xia M, Xiang J, Xie M, Xie X, Xin S, Xiong A, Xiong J, Xu D, Xu H, Xu L, Xu R, Xu T, Xu Y, Xu Z, Xu Z, Yabsley B, Yacoob S, Yamaguchi Y, Yamashita E, Yamauchi H, Yamazaki T, Yamazaki Y, Yan J, Yan S, Yan Z, Yang HJ, Yang HT, Yang S, Yang T, Yang X, Yang X, Yang Y, Yang Y, Yang Z, Yao WM, Ye H, Ye H, Ye J, Ye S, Ye X, Yeh Y, Yeletskikh I, Yeo BK, Yexley MR, Yin P, Yorita K, Younas S, Young CJS, Young C, Yu C, Yu Y, Yuan M, Yuan R, Yue L, Zaazoua M, Zabinski B, Zaid E, Zak ZK, Zakareishvili T, Zakharchuk N, Zambito S, Zamora Saa JA, Zang J, Zanzi D, Zaplatilek O, Zeitnitz C, Zeng H, Zeng JC, Zenger DT, Zenin O, Ženiš T, Zenz S, Zerradi S, Zerwas D, Zhai M, Zhang DF, Zhang J, Zhang J, Zhang K, Zhang L, Zhang P, Zhang R, Zhang S, Zhang S, Zhang T, Zhang X, Zhang X, Zhang Y, Zhang Y, Zhang Y, Zhang Z, Zhang Z, Zhao H, Zhao T, Zhao Y, Zhao Z, Zhemchugov A, Zheng J, Zheng K, Zheng X, Zheng Z, Zhong D, Zhou B, Zhou H, Zhou N, Zhou Y, Zhou Y, Zhu CG, Zhu J, Zhu Y, Zhu Y, Zhuang X, Zhukov K, Zimine NI, Zinsser J, Ziolkowski M, Živković L, Zoccoli A, Zoch K, Zorbas TG, Zormpa O, Zou W, Zwalinski L. Combination of Searches for Resonant Higgs Boson Pair Production Using pp Collisions at sqrt[s]=13 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS 2024; 132:231801. [PMID: 38905640 DOI: 10.1103/physrevlett.132.231801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/28/2023] [Accepted: 05/07/2024] [Indexed: 06/23/2024]
Abstract
A combination of searches for a new resonance decaying into a Higgs boson pair is presented, using up to 139 fb^{-1} of pp collision data at sqrt[s]=13 TeV recorded with the ATLAS detector at the LHC. The combination includes searches performed in three decay channels: bb[over ¯]bb[over ¯], bb[over ¯]τ^{+}τ^{-}, and bb[over ¯]γγ. No excess above the expected Standard Model background is observed and upper limits are set at the 95% confidence level on the production cross section of Higgs boson pairs originating from the decay of a narrow scalar resonance with mass in the range 251 GeV-5 TeV. The observed (expected) limits are in the range 0.96-600 fb (1.2-390 fb). The limits are interpreted in the type-I two-Higgs-doublet model and the minimal supersymmetric standard model, and constrain parameter space not previously excluded by other searches.
Collapse
|
40
|
Hu L, Zhang H, Huang C, Shen T, Feng Z, Mu F, Xu L, Lin Y, Yue C, Guo K, Tian M, Shi J, Zhang C, Wen P, Cao S, Wang Y, Zhang J, Shi X, Wang Z, He Y, Zhang X, Liu X, Lv Y, Liu Z, Guo W, Wang B. Effect of ursodeoxycholic acid on preventing SARS-CoV-2 infection in patients with liver transplantation: a multicenter retrospective cohort study. QJM 2024; 117:339-347. [PMID: 37950449 DOI: 10.1093/qjmed/hcad254] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/28/2023] [Revised: 10/06/2023] [Indexed: 11/12/2023] Open
Abstract
BACKGROUND Immunosuppressed recipients of liver transplantation (LT) are more likely to develop coronavirus disease 2019 (COVID-19) and may have an increased risk of developing worse outcomes. AIM To assess the effect of ursodeoxycholic acid (UDCA) on preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in LT recipients. DESIGN Adult patients (aged ≥ 18 years) who underwent LT between 1 January 2015 and 31 December 2022 were included and categorized into two groups according to their use of UDCA. METHODS The prevalence and severity of COVID-19 among transplantation patients between the UDCA and non-UDCA groups were estimated and compared. RESULTS Among the 897 LT patients who met the inclusion criteria, infection rate of SARS-CoV-2 was 78.4%, and the rate of severe illness was 5.1% from January 2022 to January 2023 in China. In the multivariate analysis, only UDCA treatment (P = 0.006) was found to be a protective factor against SARS-CoV-2 infection. After propensity score matching, the SARS-CoV-2 infection rate in the UDCA group was lower than that in the non-UDCA group (74.1% vs. 84.6%, P = 0.002). This rate was further reduced to 62.1% (P = 0.002) when the oral administration dose was >15 mg/kg/day. There was no difference in the rates of severe COVID-19 illness, ICU admission, or ventilation rate or length of hospital stay with or without UDCA treatment (all P > 0.05). CONCLUSIONS The use of UDCA in LT patients significantly reduced the SARS-CoV-2 infection rate and showed a dose-dependent protective effect.
Collapse
|
41
|
Sun J, Zhang X, Wang L, Di Stefano AFD, Zanin V, Magrone P, Yuan Y. Author Correction: Phase I study of the pharmacokinetics and safety of single and multiple doses of intravenous N-acetylcysteine in healthy Chinese subjects. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2024; 28:3806. [PMID: 38946388 DOI: 10.26355/eurrev_202406_36449] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 07/02/2024]
Abstract
Eur Rev Med Pharmacol Sci 2023; 27 (24): 12103-12111-DOI: 10.26355/eurrev_202312_34808-PMID: 38164872, published online on December 22, 2023. After publication, the authors found that Table III's legend was the same as that of Table II. Therefore, Table III's legend has been corrected as follows: Table III. Plasma PK parameters following repeat doses of IV NAC 600 mg (n = 24). There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/34808.
Collapse
|
42
|
Yuan B, Qi Y, Zhang X, Hu J, Fan Y, Ji X. The relationship of MITF gene expression and promoter methylation with plumage colour in quail. Br Poult Sci 2024; 65:259-264. [PMID: 38578288 DOI: 10.1080/00071668.2024.2326962] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Accepted: 01/16/2024] [Indexed: 04/06/2024]
Abstract
1. This study focused on the relationship between MITF mRNA expression and plumage colour in quail and the effect of promoter methylation on the expression of MITF mRNA.2. The CDS region of MITF mRNA was cloned by RT-PCR, followed by DNA sequencing. The RT-qPCR method was used to analyse the expression levels of MITF mRNA in dorsal skin tissue in Korean quail and Beijing white quail. The promoter region of the MITF gene was cloned, and the CpG island was predicted by the CpGplot program. The methylation levels of the CpG island were analysed using BS-PCR technology.3. Quail MITF mRNA contains a 1,476 bp complete ORF, which encodes a 492 amino acid residue protein. The MITF protein has no signal peptide or transmembrane region. The expression of MITF mRNA in dorsal tissue of Korean quail was significantly higher than that in Beijing white quail (p < 0.01). Abundant cis-elements and a 346 bp CpG island were found in the promoter region of the MITF gene. The average methylation level of the CpG island was 22 (22%) in Korean quail, and 46 (30%) in Beijing white quail (p < 0.05).4. The hypermethylation of the MITF gene promoter region in Beijing white quail resulted in a decrease in expression level, which was related to white feather colour.
Collapse
|
43
|
Li S, Zhang R, Zhang X, Zhang T, Cao D, Xiang Y, Yang J. Component Patterns and Survival Outcomes in Patients with Mixed Malignant Ovarian Germ Cell Tumors: A Retrospective Cohort Study. Clin Oncol (R Coll Radiol) 2024; 36:370-377. [PMID: 38555208 DOI: 10.1016/j.clon.2024.03.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2023] [Revised: 01/02/2024] [Accepted: 03/11/2024] [Indexed: 04/02/2024]
Abstract
AIMS To evaluate the component patterns and risk stratification in patients with mixed malignant ovarian germ cell tumors (mMOGCT). METHODS A retrospective study of 70 mMOGCT patients treated in our hospital between 2000 and 2022 was conducted. The recurrence-free survival (RFS), disease-specific survival (DSS), and risk stratification systems based on scoring the identified prognostic factors were assessed. RESULTS Yolk sac tumor component was the most common type (80%), followed by dysgerminoma (50%), immature teratoma (40%), embryonic carcinoma (27.1%), and chorionic carcinoma (15.7%). The 5-year RFS and DSS rates were 77.9% and 87.9%, respectively. International federation of gynecology and obstetrics (FIGO) stage III-IV (RR 3.253, P = 0.029) and normalization of tumor marker (TM) ≤ 3 cycles of chemotherapy (RR 6.249, P = 0.017) were risk factors for RFS and DSS, respectively. Significant DSS (RR 8.268, P = 0.006) was also noted between patients who had normalized TM ≤ 4 and ≥5 cycles of chemotherapy. FIGO stages I-II and stages III-IV were scored as 0 and 2, respectively. AFP normalization ≤3, 4, and ≥5 cycles of chemotherapy were scored as 0, 1, and 4, respectively. A total score of 0, 1-2, and ≥3 stratified patients into low-risk (43 patients), intermediate-risk (13 patients), and high-risk groups (14 patients), respectively. Patients in three risk stratifications manifested significant differences in DSS (P = 0.010) but not in RFS (P > 0.05). CONCLUSION Distinct different component patterns existed among mMOGCT patients, and predicting survival outcomes in a universal model was challenging.
Collapse
|
44
|
Yin Z, Zhao Q, Lv X, Zhang X, Wu Y. Circular RNA ath-circ032768, a competing endogenous RNA, response the drought stress by targeting miR472-RPS5 module. PLANT BIOLOGY (STUTTGART, GERMANY) 2024; 26:544-559. [PMID: 38588338 DOI: 10.1111/plb.13645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/21/2023] [Accepted: 02/21/2024] [Indexed: 04/10/2024]
Abstract
CircRNAs (circular RNAs) reduce the abundance of miRNAs through ceRNA (competing endogenous RNA), to regulate many physiological processes and stress responses in plants. However, the role of circRNA in drought stress is poorly understood. Through ring identification and sequencing verification of ath-circ032768, bioinformatics analysis predicted the interaction of ath-circ032768-miR472-RPS5, and further obtained transgenic plants overexpressing ath-circ032768 and silencing STTM-miR472. The change in drought stress was analysed using biochemical and molecular biological methods. Sequencing and biological analysis confirmed that ath-circ032768, miR472 and RPS5 were responsive to drought stress, and changes in gene expression were consistent with the prediction of ceRNA. The silencing vectors ath-circ032768 and STTM-miR472 were constructed using molecular biology techniques, and stable transgenic plants with drought tolerance obtained. Further physiological and biochemical studies showed that ath-circ032768 could bind to miR472, and that miR472 could bind to the RPS5 gene, resulting in decreased expression of RPS5. Hence, ath-circ032768 can competitively inhibit degradation of RPS5 by miR472 through ceRNA. This process is accompanied by increased expression of DREB2A, RD29A and RD29B genes. Through the ath-circ032768-miR472-RPS5 pathway, the RPS5 stress resistance protein interacts with DREB2A protein to enhance expression of downstream drought resistance genes, RD29A and RD29B, and participate in the regulation mechanism of plant drought resistance, thereby improving drought tolerance of plants.
Collapse
|
45
|
Wang B, Liu J, Xie J, Zhang X, Wang Z, Cao Z, Wen D, Wan Hasan WZ, Harun Ramli HR, Dong X. Systematic review and meta-analysis of the prognostic value of 18F-Fluorodeoxyglucose ( 18F-FDG) positron emission tomography (PET) and/or computed tomography (CT)-based radiomics in head and neck cancer. Clin Radiol 2024:S0009-9260(24)00282-4. [PMID: 38944542 DOI: 10.1016/j.crad.2024.05.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2023] [Revised: 05/16/2024] [Accepted: 05/24/2024] [Indexed: 07/01/2024]
Abstract
AIM Radiomics involves the extraction of quantitative data from medical images to facilitate the diagnosis, prognosis, and staging of tumors. This study provides a comprehensive overview of the efficacy of radiomics in prognostic applications for head and neck cancer (HNC) in recent years. It undertakes a systematic review of prognostic models specific to HNC and conducts a meta-analysis to evaluate their predictive performance. MATERIALS AND METHODS This study adhered rigorously to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for literature searches. The literature databases, including PubMed, Embase, Cochrane, and Scopus were systematically searched individually. The methodological quality of the incorporated studies underwent assessment utilizing the radiomics quality score (RQS) tool. A random-effects meta-analysis employing the Harrell concordance index (C-index) was conducted to evaluate the performance of all radiomics models. RESULTS Among the 388 studies retrieved, 24 studies encompassing a total of 6,978 cases were incorporated into the systematic review. Furthermore, eight studies, focusing on overall survival as an endpoint, were included in the meta-analysis. The meta-analysis revealed that the estimated random effect of the C-index for all studies utilizing radiomics alone was 0.77 (0.71-0.82), with a substantial degree of heterogeneity indicated by an I2 of 80.17%. CONCLUSIONS Based on this review, prognostic modeling utilizing radiomics has demonstrated enhanced efficacy for head and neck cancers; however, there remains room for improvement in this approach. In the future, advancements are warranted in the integration of clinical parameters and multimodal features, balancing multicenter data, as well as in feature screening and model construction within this field.
Collapse
|
46
|
Xu JL, Wang YP, Zhang X, Liu W, Huang XF, Li JQ. [Adolescent female reproductive system dysplasia: a clinical study of 356 cases]. ZHONGHUA FU CHAN KE ZA ZHI 2024; 59:360-367. [PMID: 38797565 DOI: 10.3760/cma.j.cn112141-20240209-00089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2024]
Abstract
Objective: To explore the age of onset and consultation, the main clinical manifestations, common types of combined malformations, the relationship of endometriosis, surgical prognosis and different types of proportion of adolescent female reproductive system dysplasia. Methods: The medical records of 356 patients (aged 10-19) with female reproductive system dysplasia in Women's Hospital, School of Medicine, Zhejiang University from January 2003 to August 2018 were collected and retrospectively analyzed. Results: (1) Among the 356 adolescent dysplasia patients, uterine dysplasia (23.6%, 84/356), oblique vaginal septum syndrome (OVSS; 22.5%, 80/356) and vaginal dysplasia (21.6%, 77/356) were the most frequent ones, followed by multi-sectional dysplasia (16.0%, 57/356), other types of developmental abnormalities like external genitaliaand urogenital fistula (13.5%, 48/356) and Mayer-Rokitansky-Küster-Hauser syndrome (MRKH syndrome; 2.8%, 10/356). (2) There were significant differences between the median age of onset and the age of consultation of patients with OVSS and other types of abnormalities except hymen atresia (both P<0.05). In contrast, there were no significant differences between the age of onset and the age of consultation of the patients of uterine dysplasia, vaginal dysplasia, hymen atresia, MRKH syndrome and multi-sectional dysplasia (all P>0.05). (3) The clinical manifestations were lack of specificity, and mainly abnormal finding was lower abdominal pain. (4) After admission, the majority of patients underwent comprehensive cardiopulmonary examination (71.3%, 254/356) and urinary system examination (63.5%, 226/356). Only 18.3% (65/356) of patients had completed abdominal organ examination, and 5.9% (21/356) skeletal system examination. About other systemic malformations, urological malformations were the most common (27.5%, 98/356), followed by anorectal malformation (0.6%, 2/356), heart malformations (0.3%, 1/356), and spinal malformations (0.3%, 1/356). 46.4% (84/181) of the surgical patients were diagnosed with combined endometriosis. Patients with obstructive genital tract malformations were more likely to combine with endometriosis than non-obstructive ones [50.3% (74/147) vs 29.4% (10/34); P<0.05]. However, there was no significant difference between the severity of endometriosis of those two kinds (P>0.05). (5) Totally 308 patients were followed up successfully with a median of 25.0 years old, and 20 cases were treated again; 12.0% (37/308) of them were suffering from menstrual disorder and 33.1% (102/308) of them with dysmenorrhea. Totally 130 patients had sexually active reported no sexual problems. Conclusions: Uterine dysplasia, OVSS and vaginal dysplasia are the most common syndromes in adolescent female reproductive system dysplasia along with frequent cases of coexisting urinary malformations and increasing risks of endometriosis. Meanwhile, the lack of specificity of clinical manifestations might delay the timely diagnosis and treatment after the onset of symptoms. Nonetheless, most patients could achieve good surgical outcomes.
Collapse
|
47
|
Zhang X, Song YF, Xu YL, Zeng L, Wang Y. [Association between sleep status in the first trimester and preterm birth]. ZHONGHUA FU CHAN KE ZA ZHI 2024; 59:368-374. [PMID: 38797566 DOI: 10.3760/cma.j.cn112141-20231016-00150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/29/2024]
Abstract
Objective: To investigate the relationship between sleep status in the first trimester and preterm birth. Methods: Clinical data of pregnant women who received regular prenatal examination and delivered in Peking University Third Hospital from September 1, 2019 to June 10, 2020 were collected. The Pittsburgh sleep quality index (PSQI) was used to investigate their sleep status during 8-12 weeks of gestation, and the delivery outcomes were followed up. According to the gestational age at delivery and the cause of preterm birth, they were divided into full-term delivery group (204 cases), preterm birth group (13 cases) and spontaneous preterm birth group (9 cases). The correlation between the sleep status in the first trimester and preterm birth or spontaneous preterm birth was analyzed. Results: The median PSQI score of full-term delivery group was 4.0 points (3.0, 6.0 points), which was lower than those of preterm delivery group [6.0 points (4.0, 8.0 points)] and spontaneous preterm delivery group [7.0 points (4.0, 8.0 points)], and the differences were statistically significant (all P<0.05). The proportion of pregnant women with poor sleep quality (PSQI score>7 points) in full-term delivery group [14.2% (29/204)] was lower than those in preterm delivery group (5/13) and spontaneous preterm delivery group (4/9), and the differences were statistically significant (all P<0.05). Compared with the full-term delivery group [8.0 hours (7.0, 9.0 hours)], the preterm birth group [7.0 hours (7.0, 8.0 hours)] and spontaneous preterm birth group [7.0 hours (7.0, 8.0 hours)] had significantly shorter sleep duration at night (all P<0.05). Multivariate analysis showed that PSQI score in the first trimester was an independent risk factor for preterm birth (aOR=1.22, 95%CI: 1.02-1.45; P=0.026). Pregnancy with assisted reproductive technology (aOR=5.55, 95%CI: 1.22-25.31; P=0.027), gestational diabetes mellitus (aOR=9.27, 95%CI: 1.96-43.82; P=0.005), PSQI score in the first trimester (aOR=1.27, 95%CI: 1.01-1.58; P=0.039) were independent risk factors for spontaneous preterm birth. Conclusion: Attention should be paid to the decreased sleep quality in the first trimester, which might significantly increase the risk of preterm birth and spontaneous preterm birth.
Collapse
|
48
|
Korie U, Joldoshova A, Khandakar B, Zhang X, Liang Y. Histopathology and its clinical correlation of liver biopsy in patients with treated autoimmune hepatitis. Ann Diagn Pathol 2024; 73:152333. [PMID: 38820911 DOI: 10.1016/j.anndiagpath.2024.152333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2024] [Revised: 05/20/2024] [Accepted: 05/22/2024] [Indexed: 06/02/2024]
Abstract
The diagnosis of autoimmune hepatitis (AIH) relies on well-established criteria encompassing histological, serological, and clinical features. Diagnosing AIH may become challenging when encountering patients who have undergone steroid therapy for other co-existing diseases. Thirty-nine liver biopsies from 25 patients with treated and untreated AIH were classified into three groups: 1) Newly diagnosed untreated biopsies (n = 16); 2) Newly diagnosed partially treated biopsies from patients already on steroid treatment for other co-existing diseases (n = 9); 3) Previously diagnosed biopsies from patients who had undergone complete treatment (n = 14). In the untreated AIH group, at least 50 % of the cases exhibited the following features: at least moderate portal inflammation (81 %), at least moderate lobular inflammation (56 %), ductular reaction (94 %), inflammation gradient from bile duct to interface (88 %), unequivocal interface hepatitis (100 %), emperipolesis (56 %), plasma cell cluster (88 %), apoptosis or necrosis (63 %), pericentral inflammation (63 %), and periportal fibrosis (88 %). Although all these diagnostically sensitive histologic features were present in significantly fewer cases after treatment (p < 0.05), the features of ductular reaction, inflammation gradient from bile duct to interface, pericentral inflammation, and periportal fibrosis were likely to persist after treatment, especially in partially treated cases; these features did not show a significant association with higher transaminase levels (P > 0.05) and were considered as indirect features of hepatocytic injury. Our data suggest categorizing AIH histological features into direct and indirect hepatocytic injuries. Direct hepatocytic injury features significantly correlate with transaminase levels and respond well to treatment, while indirect ones show weaker transaminase correlation and relative treatment resistance.
Collapse
|
49
|
Aad G, Abbott B, Abeling K, Abicht NJ, Abidi SH, Aboulhorma A, Abramowicz H, Abreu H, Abulaiti Y, Acharya BS, Adam Bourdarios C, Adamczyk L, Addepalli SV, Addison MJ, Adelman J, Adiguzel A, Adye T, Affolder AA, Afik Y, Agaras MN, Agarwala J, Aggarwal A, Agheorghiesei C, Ahmad A, Ahmadov F, Ahmed WS, Ahuja S, Ai X, Aielli G, Aikot A, Ait Tamlihat M, Aitbenchikh B, Aizenberg I, Akbiyik M, Åkesson TPA, Akimov AV, Akiyama D, Akolkar NN, Aktas S, Al Khoury K, Alberghi GL, Albert J, Albicocco P, Albouy GL, Alderweireldt S, Alegria ZL, Aleksa M, Aleksandrov IN, Alexa C, Alexopoulos T, Alfonsi F, Algren M, Alhroob M, Ali B, Ali HMJ, Ali S, Alibocus SW, Aliev M, Alimonti G, Alkakhi W, Allaire C, Allbrooke BMM, Allen JF, Allendes Flores CA, Allport PP, Aloisio A, Alonso F, Alpigiani C, Alvarez Estevez M, Alvarez Fernandez A, Alves Cardoso M, Alviggi MG, Aly M, Amaral Coutinho Y, Ambler A, Amelung C, Amerl M, Ames CG, Amidei D, Amor Dos Santos SP, Amos KR, Ananiev V, Anastopoulos C, Andeen T, Anders JK, Andrean SY, Andreazza A, Angelidakis S, Angerami A, Anisenkov AV, Annovi A, Antel C, Anthony MT, Antipov E, Antonelli M, Anulli F, Aoki M, Aoki T, Aparisi Pozo JA, Aparo MA, Aperio Bella L, Appelt C, Apyan A, Aranzabal N, Arbiol Val SJ, Arcangeletti C, Arce ATH, Arena E, Arguin JF, Argyropoulos S, Arling JH, Arnaez O, Arnold H, Artoni G, Asada H, Asai K, Asai S, Asbah NA, Assamagan K, Astalos R, Atashi S, Atkin RJ, Atkinson M, Atmani H, Atmasiddha PA, Augsten K, Auricchio S, Auriol AD, Austrup VA, Avolio G, Axiotis K, Azuelos G, Babal D, Bachacou H, Bachas K, Bachiu A, Backman F, Badea A, Baer TM, Bagnaia P, Bahmani M, Bahner D, Bailey AJ, Bailey VR, Baines JT, Baines L, Baker OK, Bakos E, Bakshi Gupta D, Balakrishnan V, Balasubramanian R, Baldin EM, Balek P, Ballabene E, Balli F, Baltes LM, Balunas WK, Balz J, Banas E, Bandieramonte M, Bandyopadhyay A, Bansal S, Barak L, Barakat M, Barberio EL, Barberis D, Barbero M, Barel MZ, Barends KN, Barillari T, Barisits MS, Barklow T, Baron P, Baron Moreno DA, Baroncelli A, Barone G, Barr AJ, Barr JD, Barranco Navarro L, Barreiro F, Barreiro Guimarães da Costa J, Barron U, Barros Teixeira MG, Barsov S, Bartels F, Bartoldus R, Barton AE, Bartos P, Basan A, Baselga M, Bassalat A, Basso MJ, Basson CR, Bates RL, Batlamous S, Batley JR, Batool B, Battaglia M, Battulga D, Bauce M, Bauer M, Bauer P, Bazzano Hurrell LT, Beacham JB, Beau T, Beaucamp JY, Beauchemin PH, Becherer F, Bechtle P, Beck HP, Becker K, Beddall AJ, Bednyakov VA, Bee CP, Beemster LJ, Beermann TA, Begalli M, Begel M, Behera A, Behr JK, Beirer JF, Beisiegel F, Belfkir M, Bella G, Bellagamba L, Bellerive A, Bellos P, Beloborodov K, Benchekroun D, Bendebba F, Benhammou Y, Benoit M, Bensinger JR, Bentvelsen S, Beresford L, Beretta M, Bergeaas Kuutmann E, Berger N, Bergmann B, Beringer J, Bernardi G, Bernius C, Bernlochner FU, Bernon F, Berrocal Guardia A, Berry T, Berta P, Berthold A, Bertram IA, Bethke S, Betti A, Bevan AJ, Bhalla NK, Bhamjee M, Bhatta S, Bhattacharya DS, Bhattarai P, Bhopatkar VS, Bi R, Bianchi RM, Bianco G, Biebel O, Bielski R, Biglietti M, Bindi M, Bingul A, Bini C, Biondini A, Birch-Sykes CJ, Bird GA, Birman M, Biros M, Biryukov S, Bisanz T, Bisceglie E, Biswal JP, Biswas D, Bitadze A, Bjørke K, Bloch I, Blue A, Blumenschein U, Blumenthal J, Bobbink GJ, Bobrovnikov VS, Boehler M, Boehm B, Bogavac D, Bogdanchikov AG, Bohm C, Boisvert V, Bokan P, Bold T, Bomben M, Bona M, Boonekamp M, Booth CD, Borbély AG, Bordulev IS, Borecka-Bielska HM, Borissov G, Bortoletto D, Boscherini D, Bosman M, Bossio Sola JD, Bouaouda K, Bouchhar N, Boudreau J, Bouhova-Thacker EV, Boumediene D, Bouquet R, Boveia A, Boyd J, Boye D, Boyko IR, Bracinik J, Brahimi N, Brandt G, Brandt O, Braren F, Brau B, Brau JE, Brener R, Brenner L, Brenner R, Bressler S, Britton D, Britzger D, Brock I, Brooijmans G, Brooks WK, Brost E, Brown LM, Bruce LE, Bruckler TL, Bruckman de Renstrom PA, Brüers B, Bruni A, Bruni G, Bruschi M, Bruscino N, Buanes T, Buat Q, Buchin D, Buckley AG, Bulekov O, Bullard BA, Burdin S, Burgard CD, Burger AM, Burghgrave B, Burlayenko O, Burr JTP, Burton CD, Burzynski JC, Busch EL, Büscher V, Bussey PJ, Butler JM, Buttar CM, Butterworth JM, Buttinger W, Buxo Vazquez CJ, Buzykaev AR, Cabrera Urbán S, Cadamuro L, Caforio D, Cai H, Cai Y, Cai Y, Cairo VMM, Cakir O, Calace N, Calafiura P, Calderini G, Calfayan P, Callea G, Caloba LP, Calvet D, Calvet S, Calvet TP, Calvetti M, Camacho Toro R, Camarda S, Camarero Munoz D, Camarri P, Camerlingo MT, Cameron D, Camincher C, Campanelli M, Camplani A, Canale V, Canesse A, Cantero J, Cao Y, Capocasa F, Capua M, Carbone A, Cardarelli R, Cardenas JCJ, Cardillo F, Carducci G, Carli T, Carlino G, Carlotto JI, Carlson BT, Carlson EM, Carminati L, Carnelli A, Carnesale M, Caron S, Carquin E, Carrá S, Carratta G, Carrio Argos F, Carter JWS, Carter TM, Casado MP, Caspar M, Castillo FL, Castillo Garcia L, Castillo Gimenez V, Castro NF, Catinaccio A, Catmore JR, Cavaliere V, Cavalli N, Cavasinni V, Cekmecelioglu YC, Celebi E, Celli F, Centonze MS, Cepaitis V, Cerny K, Cerqueira AS, Cerri A, Cerrito L, Cerutti F, Cervato B, Cervelli A, Cesarini G, Cetin SA, Chakraborty D, Chan J, Chan WY, Chapman JD, Chapon E, Chargeishvili B, Charlton DG, Charman TP, Chatterjee M, Chauhan C, Chekanov S, Chekulaev SV, Chelkov GA, Chen A, Chen B, Chen B, Chen H, Chen H, Chen J, Chen J, Chen M, Chen S, Chen SJ, Chen X, Chen X, Chen Y, Cheng CL, Cheng HC, Cheong S, Cheplakov A, Cheremushkina E, Cherepanova E, Cherkaoui El Moursli R, Cheu E, Cheung K, Chevalier L, Chiarella V, Chiarelli G, Chiedde N, Chiodini G, Chisholm AS, Chitan A, Chitishvili M, Chizhov MV, Choi K, Chomont AR, Chou Y, Chow EYS, Chowdhury T, Chu KL, Chu MC, Chu X, Chudoba J, Chwastowski JJ, Cieri D, Ciesla KM, Cindro V, Ciocio A, Cirotto F, Citron ZH, Citterio M, Ciubotaru DA, Clark A, Clark PJ, Clarry C, Clavijo Columbie JM, Clawson SE, Clement C, Clercx J, Coadou Y, Cobal M, Coccaro A, Barrue RFC, Coelho Lopes De Sa R, Coelli S, Coimbra AEC, Cole B, Collot J, Conde Muiño P, Connell MP, Connell SH, Connelly IA, Conroy EI, Conventi F, Cooke HG, Cooper-Sarkar AM, Cordeiro Oudot Choi A, Corpe LD, Corradi M, Corriveau F, Cortes-Gonzalez A, Costa MJ, Costanza F, Costanzo D, Cote BM, Cowan G, Cranmer K, Cremonini D, Crépé-Renaudin S, Crescioli F, Cristinziani M, Cristoforetti M, Croft V, Crosby JE, Crosetti G, Cueto A, Cuhadar Donszelmann T, Cui H, Cui Z, Cunningham WR, Curcio F, Czodrowski P, Czurylo MM, De Sousa MJDCS, Da Fonseca Pinto JV, Da Via C, Dabrowski W, Dado T, Dahbi S, Dai T, Dal Santo D, Dallapiccola C, Dam M, D'amen G, D'Amico V, Damp J, Dandoy JR, Daneri MF, Danninger M, Dao V, Darbo G, Darmora S, Das SJ, D'Auria S, David C, Davidek T, Davis-Purcell B, Dawson I, Day-Hall HA, De K, De Asmundis R, De Biase N, De Castro S, De Groot N, de Jong P, De la Torre H, De Maria A, De Salvo A, De Sanctis U, De Santis F, De Santo A, De Vivie De Regie JB, Dedovich DV, Degens J, Deiana AM, Del Corso F, Del Peso J, Del Rio F, Delagrange L, Deliot F, Delitzsch CM, Della Pietra M, Della Volpe D, Dell'Acqua A, Dell'Asta L, Delmastro M, Delsart PA, Demers S, Demichev M, Denisov SP, D'Eramo L, Derendarz D, Derue F, Dervan P, Desch K, Deutsch C, Di Bello FA, Di Ciaccio A, Di Ciaccio L, Di Domenico A, Di Donato C, Di Girolamo A, Di Gregorio G, Di Luca A, Di Micco B, Di Nardo R, Diaconu C, Diamantopoulou M, Dias FA, Vale TDD, Diaz MA, Diaz Capriles FG, Didenko M, Diehl EB, Diehl L, Díez Cornell S, Diez Pardos C, Dimitriadi C, Dimitrievska A, Dingfelder J, Dinu IM, Dittmeier SJ, Dittus F, Djama F, Djobava T, Djuvsland JI, Doglioni C, Dohnalova A, Dolejsi J, Dolezal Z, Dona KM, Donadelli M, Dong B, Donini J, D'Onofrio A, D'Onofrio M, Dopke J, Doria A, Dos Santos Fernandes N, Dougan P, Dova MT, Doyle AT, Draguet MA, Dreyer E, Drivas-Koulouris I, Drnevich M, Drobac AS, Drozdova M, Du D, du Pree TA, Dubinin F, Dubovsky M, Duchovni E, Duckeck G, Ducu OA, Duda D, Dudarev A, Duden ER, D'uffizi M, Duflot L, Dührssen M, Dülsen C, Dumitriu AE, Dunford M, Dungs S, Dunne K, Duperrin A, Yildiz HD, Düren M, Durglishvili A, Dwyer BL, Dyckes GI, Dyndal M, Dziedzic BS, Earnshaw ZO, Eberwein GH, Eckerova B, Eggebrecht S, Purcino De Souza EE, Ehrke LF, Eigen G, Einsweiler K, Ekelof T, Ekman PA, El Farkh S, El Ghazali Y, El Jarrari H, El Moussaouy A, Ellajosyula V, Ellert M, Ellinghaus F, Ellis N, Elmsheuser J, Elsing M, Emeliyanov D, Enari Y, Ene I, Epari S, Erdmann J, Erland PA, Errenst M, Escalier M, Escobar C, Etzion E, Evans G, Evans H, Evans LS, Evans MO, Ezhilov A, Ezzarqtouni S, Fabbri F, Fabbri L, Facini G, Fadeyev V, Fakhrutdinov RM, Falciano S, Falda Ulhoa Coelho LF, Falke PJ, Faltova J, Fan C, Fan Y, Fang Y, Fanti M, Faraj M, Farazpay Z, Farbin A, Farilla A, Farooque T, Farrington SM, Fassi F, Fassouliotis D, Faucci Giannelli M, Fawcett WJ, Fayard L, Federic P, Federicova P, Fedin OL, Fedotov G, Feickert M, Feligioni L, Fellers DE, Feng C, Feng M, Feng Z, Fenton MJ, Fenyuk AB, Ferencz L, Ferguson RAM, Fernandez Luengo SI, Fernandez Martinez P, Fernoux MJV, Ferrando J, Ferrari A, Ferrari P, Ferrari R, Ferrere D, Ferretti C, Fiedler F, Fiedler P, Filipčič A, Filmer EK, Filthaut F, Fiolhais MCN, Fiorini L, Fisher WC, Fitschen T, Fitzhugh PM, Fleck I, Fleischmann P, Flick T, Flores M, Flores Castillo LR, Flores Sanz De Acedo L, Follega FM, Fomin N, Foo JH, Forland BC, Formica A, Forti AC, Fortin E, Fortman AW, Foti MG, Fountas L, Fournier D, Fox H, Francavilla P, Francescato S, Franchellucci S, Franchini M, Franchino S, Francis D, Franco L, Franco Lima V, Franconi L, Franklin M, Frattari G, Freegard AC, Freund WS, Frid YY, Friend J, Fritzsche N, Froch A, Froidevaux D, Frost JA, Fu Y, Fuenzalida Garrido S, Fujimoto M, Fung KY, De Simas Filho EF, Furukawa M, Fuster J, Gabrielli A, Gabrielli A, Gadow P, Gagliardi G, Gagnon LG, Gallas EJ, Gallop BJ, Gan KK, Ganguly S, Gao Y, Garay Walls FM, Garcia B, García C, Garcia Alonso A, Garcia Caffaro AG, García Navarro JE, Garcia-Sciveres M, Gardner GL, Gardner RW, Garelli N, Garg D, Garg RB, Gargan JM, Garner CA, Garvey CM, Gaspar P, Gassmann VK, Gaudio G, Gautam V, Gauzzi P, Gavrilenko IL, Gavrilyuk A, Gay C, Gaycken G, Gazis EN, Geanta AA, Gee CM, Gekow A, Gemme C, Genest MH, Gentile S, Gentry AD, George S, George WF, Geralis T, Gessinger-Befurt P, Geyik ME, Ghani M, Ghneimat M, Ghorbanian K, Ghosal A, Ghosh A, Ghosh A, Giacobbe B, Giagu S, Giani T, Giannetti P, Giannini A, Gibson SM, Gignac M, Gil DT, Gilbert AK, Gilbert BJ, Gillberg D, Gilles G, Gillwald NEK, Ginabat L, Gingrich DM, Giordani MP, Giraud PF, Giugliarelli G, Giugni D, Giuli F, Gkialas I, Gladilin LK, Glasman C, Gledhill GR, Glemža G, Glisic M, Gnesi I, Go Y, Goblirsch-Kolb M, Gocke B, Godin D, Gokturk B, Goldfarb S, Golling T, Gololo MGD, Golubkov D, Gombas JP, Gomes A, Gomes Da Silva G, Gomez Delegido AJ, Gonçalo R, Gonella G, Gonella L, Gongadze A, Gonnella F, Gonski JL, González Andana RY, González de la Hoz S, Gonzalez Fernandez S, Gonzalez Lopez R, Gonzalez Renteria C, Gonzalez Rodrigues MV, Gonzalez Suarez R, Gonzalez-Sevilla S, Gonzalvo Rodriguez GR, Goossens L, Gorini B, Gorini E, Gorišek A, Gosart TC, Goshaw AT, Gostkin MI, Goswami S, Gottardo CA, Gotz SA, Gouighri M, Goumarre V, Goussiou AG, Govender N, Grabowska-Bold I, Graham K, Gramstad E, Grancagnolo S, Grandi M, Grant CM, Gravila PM, Gravili FG, Gray HM, Greco M, Grefe C, Gregor IM, Grenier P, Grewe SG, Grieco C, Grillo AA, Grimm K, Grinstein S, Grivaz JF, Gross E, Grosse-Knetter J, Grud C, Grundy JC, Guan L, Guan W, Gubbels C, Guerrero Rojas JGR, Guerrieri G, Guescini F, Gugel R, Guhit JAM, Guida A, Guilloton E, Guindon S, Guo F, Guo J, Guo L, Guo Y, Gupta R, Gupta R, Gurbuz S, Gurdasani SS, Gustavino G, Guth M, Gutierrez P, Gutierrez Zagazeta LF, Gutsche M, Gutschow C, Gwenlan C, Gwilliam CB, Haaland ES, Haas A, Habedank M, Haber C, Hadavand HK, Hadef A, Hadzic S, Hagan AI, Hahn JJ, Haines EH, Haleem M, Haley J, Hall JJ, Hallewell GD, Halser L, Hamano K, Hamer M, Hamity GN, Hampshire EJ, Han J, Han K, Han L, Han L, Han S, Han YF, Hanagaki K, Hance M, Hangal DA, Hanif H, Hank MD, Hankache R, Hansen JB, Hansen JD, Hansen PH, Hara K, Harada D, Harenberg T, Harkusha S, Harris ML, Harris YT, Harrison J, Harrison NM, Harrison PF, Hartman NM, Hartmann NM, Hasegawa Y, Hauser R, Hawkes CM, Hawkings RJ, Hayashi Y, Hayashida S, Hayden D, Hayes C, Hayes RL, Hays CP, Hays JM, Hayward HS, He F, He M, He Y, He Y, Heatley NB, Hedberg V, Heggelund AL, Hehir ND, Heidegger C, Heidegger KK, Heidorn WD, Heilman J, Heim S, Heim T, Heinlein JG, Heinrich JJ, Heinrich L, Hejbal J, Helary L, Held A, Hellesund S, Helling CM, Hellman S, Henderson RCW, Henkelmann L, Henriques Correia AM, Herde H, Hernández Jiménez Y, Herrmann LM, Herrmann T, Herten G, Hertenberger R, Hervas L, Hesping ME, Hessey NP, Hibi H, Hill E, Hillier SJ, Hinds JR, Hinterkeuser F, Hirose M, Hirose S, Hirschbuehl D, Hitchings TG, Hiti B, Hobbs J, Hobincu R, Hod N, Hodgkinson MC, Hodkinson BH, Hoecker A, Hofer DD, Hofer J, Holm T, Holzbock M, Hommels LBAH, Honan BP, Hong J, Hong TM, Hooberman BH, Hopkins WH, Horii Y, Hou S, Howard AS, Howarth J, Hoya J, Hrabovsky M, Hrynevich A, Hryn'ova T, Hsu PJ, Hsu SC, Hu Q, Hu YF, Huang S, Huang X, Huang X, Huang Y, Huang Y, Huang Z, Hubacek Z, Huebner M, Huegging F, Huffman TB, Hugli CA, Huhtinen M, Huiberts SK, Hulsken R, Huseynov N, Huston J, Huth J, Hyneman R, Iacobucci G, Iakovidis G, Ibragimov I, Iconomidou-Fayard L, Iengo P, Iguchi R, Iizawa T, Ikegami Y, Ilic N, Imam H, Ince Lezki M, Ingebretsen Carlson T, Introzzi G, Iodice M, Ippolito V, Irwin RK, Ishino M, Islam W, Issever C, Istin S, Ito H, Iturbe Ponce JM, Iuppa R, Ivina A, Izen JM, Izzo V, Jacka P, Jackson P, Jacobs RM, Jaeger BP, Jagfeld CS, Jain G, Jain P, Jakobs K, Jakoubek T, Jamieson J, Janas KW, Javurkova M, Jeanneau F, Jeanty L, Jejelava J, Jenni P, Jessiman CE, Jézéquel S, Jia C, Jia J, Jia X, Jia X, Jia Z, Jiggins S, Jimenez Pena J, Jin S, Jinaru A, Jinnouchi O, Johansson P, Johns KA, Johnson JW, Jones DM, Jones E, Jones P, Jones RWL, Jones TJ, Joos HL, Joshi R, Jovicevic J, Ju X, Junggeburth JJ, Junkermann T, Juste Rozas A, Juzek MK, Kabana S, Kaczmarska A, Kado M, Kagan H, Kagan M, Kahn A, Kahn A, Kahra C, Kaji T, Kajomovitz E, Kakati N, Kalaitzidou I, Kalderon CW, Kamenshchikov A, Kang NJ, Kar D, Karava K, Kareem MJ, Karentzos E, Karkanias I, Karkout O, Karpov SN, Karpova ZM, Kartvelishvili V, Karyukhin AN, Kasimi E, Katzy J, Kaur S, Kawade K, Kawale MP, Kawamoto C, Kawamoto T, Kay EF, Kaya FI, Kazakos S, Kazanin VF, Ke Y, Keaveney JM, Keeler R, Kehris GV, Keller JS, Kelly AS, Kempster JJ, Kennedy KE, Kennedy PD, Kepka O, Kerridge BP, Kersten S, Kerševan BP, Keshri S, Keszeghova L, Ketabchi Haghighat S, Khan RA, Khandoga M, Khanov A, Kharlamov AG, Kharlamova T, Khoda EE, Kholodenko M, Khoo TJ, Khoriauli G, Khubua J, Khwaira YAR, Kilgallon A, Kim DW, Kim YK, Kimura N, Kingston MK, Kirchhoff A, Kirfel C, Kirfel F, Kirk J, Kiryunin AE, Kitsaki C, Kivernyk O, Klassen M, Klein C, Klein L, Klein MH, Klein M, Klein SB, Klein U, Klimek P, Klimentov A, Klioutchnikova T, Kluit P, Kluth S, Kneringer E, Knight TM, Knue A, Kobayashi R, Kobylianskii D, Koch SF, Kocian M, Kodyš P, Koeck DM, Koenig PT, Koffas T, Kolay O, Koletsou I, Komarek T, Köneke K, Kong AXY, Kono T, Konstantinidis N, Kontaxakis P, Konya B, Kopeliansky R, Koperny S, Korcyl K, Kordas K, Koren G, Korn A, Korn S, Korolkov I, Korotkova N, Kortman B, Kortner O, Kortner S, Kostecka WH, Kostyukhin VV, Kotsokechagia A, Kotwal A, Koulouris A, Kourkoumeli-Charalampidi A, Kourkoumelis C, Kourlitis E, Kovanda O, Kowalewski R, Kozanecki W, Kozhin AS, Kramarenko VA, Kramberger G, Kramer P, Krasny MW, Krasznahorkay A, Kraus JW, Krauth LM, Kremer JA, Kresse T, Kretzschmar J, Kreul K, Krieger P, Krishnamurthy S, Krivos M, Krizka K, Kroeninger K, Kroha H, Kroll J, Kroll J, Krowpman KS, Kruchonak U, Krüger H, Krumnack N, Kruse MC, Kuchinskaia O, Kuday S, Kuehn S, Kuesters R, Kuhl T, Kukhtin V, Kulchitsky Y, Kuleshov S, Kumar M, Kumari N, Kupco A, Kupfer T, Kupich A, Kuprash O, Kurashige H, Kurchaninov LL, Kurdysh O, Kurochkin YA, Kurova A, Kuze M, Kvam AK, Kvita J, Kwan T, Kyriacou NG, Laatu LAO, Lacasta C, Lacava F, Lacker H, Lacour D, Lad NN, Ladygin E, Laforge B, Lagouri T, Lahbabi FZ, Lai S, Lakomiec IK, Lalloue N, Lambert JE, Lammers S, Lampl W, Lampoudis C, Lancaster AN, Lançon E, Landgraf U, Landon MPJ, Lang VS, Langenberg RJ, Langrekken OKB, Lankford AJ, Lanni F, Lantzsch K, Lanza A, Lapertosa A, Laporte JF, Lari T, Lasagni Manghi F, Lassnig M, Latonova V, Laudrain A, Laurier A, Lawlor SD, Lawrence Z, Lazaridou R, Lazzaroni M, Le B, Le Boulicaut EM, Leban B, Lebedev A, LeBlanc M, Ledroit-Guillon F, Lee ACA, Lee SC, Lee S, Lee TF, Leeuw LL, Lefebvre HP, Lefebvre M, Leggett C, Lehmann Miotto G, Leigh M, Leight WA, Leinonen W, Leisos A, Leite MAL, Leitgeb CE, Leitner R, Leney KJC, Lenz T, Leone S, Leonidopoulos C, Leopold A, Leroy C, Les R, Lester CG, Levchenko M, Levêque J, Levin D, Levinson LJ, Lewicki MP, Lewis DJ, Li A, Li B, Li C, Li CQ, Li H, Li H, Li H, Li H, Li H, Li J, Li K, Li L, Li M, Li QY, Li S, Li S, Li T, Li X, Li Z, Li Z, Li Z, Li Z, Liang S, Liang Z, Liberatore M, Liberti B, Lie K, Lieber Marin J, Lien H, Lin K, Lindley RE, Lindon JH, Lipeles E, Lipniacka A, Lister A, Little JD, Liu B, Liu BX, Liu D, Liu JB, Liu JKK, Liu K, Liu M, Liu MY, Liu P, Liu Q, Liu X, Liu Y, Liu YL, Liu YW, Llorente Merino J, Lloyd SL, Lobodzinska EM, Loch P, Lohse T, Lohwasser K, Loiacono E, Lokajicek M, Lomas JD, Long JD, Longarini I, Longo L, Longo R, Lopez Paz I, Lopez Solis A, Lorenzo Martinez N, Lory AM, Löschcke Centeno G, Loseva O, Lou X, Lou X, Lounis A, Love J, Love PA, Lu G, Lu M, Lu S, Lu YJ, Lubatti HJ, Luci C, Lucio Alves FL, Lucotte A, Luehring F, Luise I, Lukianchuk O, Lundberg O, Lund-Jensen B, Luongo NA, Lutz MS, Lux AB, Lynn D, Lyons H, Lysak R, Lytken E, Lyubushkin V, Lyubushkina T, Lyukova MM, Ma H, Ma K, Ma LL, Ma W, Ma Y, Mac Donell DM, Maccarrone G, MacDonald JC, Machado De Abreu Farias PC, Madar R, Mader WF, Madula T, Maeda J, Maeno T, Maguire H, Maiboroda V, Maio A, Maj K, Majersky O, Majewski S, Makovec N, Maksimovic V, Malaescu B, Malecki P, Maleev VP, Malek F, Mali M, Malito D, Mallik U, Maltezos S, Malyukov S, Mamuzic J, Mancini G, Manco G, Mandalia JP, Mandić I, Manhaes de Andrade Filho L, Maniatis IM, Manjarres Ramos J, Mankad DC, Mann A, Mansoulie B, Manzoni S, Mao L, Mapekula X, Marantis A, Marchiori G, Marcisovsky M, Marcon C, Marinescu M, Marium S, Marjanovic M, Marshall EJ, Marshall Z, Marti-Garcia S, Martin TA, Martin VJ, Martin Dit Latour B, Martinelli L, Martinez M, Martinez Agullo P, Martinez Outschoorn VI, Martinez Suarez P, Martin-Haugh S, Martoiu VS, Martyniuk AC, Marzin A, Mascione D, Masetti L, Mashimo T, Masik J, Maslennikov AL, Massa L, Massarotti P, Mastrandrea P, Mastroberardino A, Masubuchi T, Mathisen T, Matousek J, Matsuzawa N, Maurer J, Maček B, Maximov DA, Mazini R, Maznas I, Mazza M, Mazza SM, Mazzeo E, Mc Ginn C, Mc Gowan JP, Mc Kee SP, McDonald EF, McDougall AE, Mcfayden JA, McGovern RP, Mchedlidze G, Mckenzie RP, Mclachlan TC, Mclaughlin DJ, McMahon SJ, Mcpartland CM, McPherson RA, Mehlhase S, Mehta A, Melini D, Mellado Garcia BR, Melo AH, Meloni F, Mendes Jacques Da Costa AM, Meng HY, Meng L, Menke S, Mentink M, Meoni E, Mercado G, Merlassino C, Merola L, Meroni C, Merz G, Metcalfe J, Mete AS, Meyer C, Meyer JP, Middleton RP, Mijović L, Mikenberg G, Mikestikova M, Mikuž M, Mildner H, Milic A, Milke CD, Miller DW, Miller LS, Milov A, Milstead DA, Min T, Minaenko AA, Minashvili IA, Mince L, Mincer AI, Mindur B, Mineev M, Mino Y, Mir LM, Miralles Lopez M, Mironova M, Mishima A, Missio MC, Mitra A, Mitsou VA, Mitsumori Y, Miu O, Miyagawa PS, Mkrtchyan T, Mlinarevic M, Mlinarevic T, Mlynarikova M, Mobius S, Moder P, Mogg P, Mohamed Farook MH, Mohammed AF, Mohapatra S, Mokgatitswane G, Moleri L, Mondal B, Mondal S, Mönig K, Monnier E, Monsonis Romero L, Montejo Berlingen J, Montella M, Montereali F, Monticelli F, Monzani S, Morange N, De Carvalho ALM, Moreno Llácer M, Moreno Martinez C, Morettini P, Morgenstern S, Morii M, Morinaga M, Morley AK, Morodei F, Morvaj L, Moschovakos P, Moser B, Mosidze M, Moskalets T, Moskvitina P, Moss J, Moyse EJW, Mtintsilana O, Muanza S, Mueller J, Muenstermann D, Müller R, Mullier GA, Mullin AJ, Mullin JJ, Mungo DP, Munoz Perez D, Munoz Sanchez FJ, Murin M, Murray WJ, Murrone A, Muškinja M, Mwewa C, Myagkov AG, Myers AJ, Myers G, Myska M, Nachman BP, Nackenhorst O, Nag A, Nagai K, Nagano K, Nagle JL, Nagy E, Nairz AM, Nakahama Y, Nakamura K, Nakkalil K, Nanjo H, Narayan R, Narayanan EA, Naryshkin I, Naseri M, Nasri S, Nass C, Navarro G, Navarro-Gonzalez J, Nayak R, Nayaz A, Nechaeva PY, Nechansky F, Nedic L, Neep TJ, Negri A, Negrini M, Nellist C, Nelson C, Nelson K, Nemecek S, Nessi M, Neubauer MS, Neuhaus F, Neundorf J, Newhouse R, Newman PR, Ng CW, Ng YWY, Ngair B, Nguyen HDN, Nickerson RB, Nicolaidou R, Nielsen J, Niemeyer M, Niermann J, Nikiforou N, Nikolaenko V, Nikolic-Audit I, Nikolopoulos K, Nilsson P, Ninca I, Nindhito HR, Ninio G, Nisati A, Nishu N, Nisius R, Nitschke JE, Nkadimeng EK, Nobe T, Noel DL, Nommensen T, Norfolk MB, Norisam RRB, Norman BJ, Noury M, Novak J, Novak T, Novotny L, Novotny R, Nozka L, Ntekas K, Nunes De Moura Junior NMJ, Nurse E, Ocariz J, Ochi A, Ochoa I, Oerdek S, Offermann JT, Ogrodnik A, Oh A, Ohm CC, Oide H, Oishi R, Ojeda ML, O'Keefe MW, Okumura Y, Seabra LFO, Olivares Pino SA, Oliveira Damazio D, Oliveira Goncalves D, Oliver JL, Öncel ÖO, O'Neill AP, Onofre A, Onyisi PUE, Oreglia MJ, Orellana GE, Orestano D, Orlando N, Orr RS, O'Shea V, Osojnak LM, Ospanov R, Otero Y Garzon G, Otono H, Ott PS, Ottino GJ, Ouchrif M, Ouellette J, Ould-Saada F, Owen M, Owen RE, Oyulmaz KY, Ozcan VE, Ozturk F, Ozturk N, Ozturk S, Pacey HA, Pacheco Pages A, Padilla Aranda C, Padovano G, Pagan Griso S, Palacino G, Palazzo A, Palestini S, Pan J, Pan T, Panchal DK, Pandini CE, Panduro Vazquez JG, Pandya HD, Pang H, Pani P, Panizzo G, Paolozzi L, Papadatos C, Parajuli S, Paramonov A, Paraskevopoulos C, Paredes Hernandez D, Park KR, Park TH, Parker MA, Parodi F, Parrish EW, Parrish VA, Parsons JA, Parzefall U, Pascual Dias B, Pascual Dominguez L, Pasqualucci E, Passaggio S, Pastore F, Pasuwan P, Patel P, Patel UM, Pater JR, Pauly T, Pearkes J, Pedersen M, Pedro R, Peleganchuk SV, Penc O, Pender EA, Penski KE, Penzin M, Peralva BS, Peixoto APP, Pereira Sanchez L, Perepelitsa DV, Perez Codina E, Perganti M, Perini L, Pernegger H, Perrin O, Peters K, Peters RFY, Petersen BA, Petersen TC, Petit E, Petousis V, Petridou C, Petrukhin A, Pettee M, Pettersson NE, Petukhov A, Petukhova K, Pezoa R, Pezzotti L, Pezzullo G, Pham TM, Pham T, Phillips PW, Piacquadio G, Pianori E, Piazza F, Piegaia R, Pietreanu D, Pilkington AD, Pinamonti M, Pinfold JL, Pereira BCP, Pinto Pinoargote AE, Pintucci L, Piper KM, Pirttikoski A, Pizzi DA, Pizzimento L, Pizzini A, Pleier MA, Plesanovs V, Pleskot V, Plotnikova E, Poddar G, Poettgen R, Poggioli L, Pokharel I, Polacek S, Polesello G, Poley A, Polifka R, Polini A, Pollard CS, Pollock ZB, Polychronakos V, Pompa Pacchi E, Ponomarenko D, Pontecorvo L, Popa S, Popeneciu GA, Poreba A, Portillo Quintero DM, Pospisil S, Postill MA, Postolache P, Potamianos K, Potepa PA, Potrap IN, Potter CJ, Potti H, Poulsen T, Poveda J, Pozo Astigarraga ME, Prades Ibanez A, Pretel J, Price D, Primavera M, Principe Martin MA, Privara R, Procter T, Proffitt ML, Proklova N, Prokofiev K, Proto G, Protopopescu S, Proudfoot J, Przybycien M, Przygoda WW, Puddefoot JE, Pudzha D, Pyatiizbyantseva D, Qian J, Qichen D, Qin Y, Qiu T, Quadt A, Queitsch-Maitland M, Quetant G, Quinn RP, Rabanal Bolanos G, Rafanoharana D, Ragusa F, Rainbolt JL, Raine JA, Rajagopalan S, Ramakoti E, Ramirez-Berend IA, Ran K, Rapheeha NP, Rasheed H, Raskina V, Rassloff DF, Rave S, Ravina B, Ravinovich I, Raymond M, Read AL, Readioff NP, Rebuzzi DM, Redlinger G, Reed AS, Reeves K, Reidelsturz JA, Reikher D, Rej A, Rembser C, Renardi A, Renda M, Rendel MB, Renner F, Rennie AG, Rescia AL, Resconi S, Ressegotti M, Rettie S, Reyes Rivera JG, Reynolds E, Rezanova OL, Reznicek P, Ribaric N, Ricci E, Richter R, Richter S, Richter-Was E, Ridel M, Ridouani S, Rieck P, Riedler P, Riefel EM, Rieger JO, Rijssenbeek M, Rimoldi A, Rimoldi M, Rinaldi L, Rinn TT, Rinnagel MP, Ripellino G, Riu I, Rivadeneira P, Rivera Vergara JC, Rizatdinova F, Rizvi E, Roberts BA, Roberts BR, Robertson SH, Robinson D, Robles Gajardo CM, Robles Manzano M, Robson A, Rocchi A, Roda C, Rodriguez Bosca S, Rodriguez Garcia Y, Rodriguez Rodriguez A, Rodríguez Vera AM, Roe S, Roemer JT, Roepe-Gier AR, Roggel J, Røhne O, Rojas RA, Roland CPA, Roloff J, Romaniouk A, Romano E, Romano M, Romero Hernandez AC, Rompotis N, Roos L, Rosati S, Rosser BJ, Rossi E, Rossi E, Rossi LP, Rossini L, Rosten R, Rotaru M, Rottler B, Rougier C, Rousseau D, Rousso D, Roy A, Roy-Garand S, Rozanov A, Rozario ZMA, Rozen Y, Ruan X, Rubio Jimenez A, Ruby AJ, Ruelas Rivera VH, Ruggeri TA, Ruggiero A, Ruiz-Martinez A, Rummler A, Rurikova Z, Rusakovich NA, Russell HL, Russo G, Rutherfoord JP, Rutherford Colmenares S, Rybacki K, Rybar M, Rye EB, Ryzhov A, Sabater Iglesias JA, Sabatini P, Sadrozinski HFW, Safai Tehrani F, Safarzadeh Samani B, Safdari M, Saha S, Sahinsoy M, Saibel A, Saimpert M, Saito M, Saito T, Salamani D, Salnikov A, Salt J, Salvador Salas A, Salvatore D, Salvatore F, Salzburger A, Sammel D, Sampsonidis D, Sampsonidou D, Sánchez J, Sanchez Pineda A, Sanchez Sebastian V, Sandaker H, Sander CO, Sandesara JA, Sandhoff M, Sandoval C, Sankey DPC, Sano T, Sansoni A, Santi L, Santoni C, Santos H, Santpur SN, Santra A, Saoucha KA, Saraiva JG, Sardain J, Sasaki O, Sato K, Sauer C, Sauerburger F, Sauvan E, Savard P, Sawada R, Sawyer C, Sawyer L, Sayago Galvan I, Sbarra C, Sbrizzi A, Scanlon T, Schaarschmidt J, Schacht P, Schäfer U, Schaffer AC, Schaile D, Schamberger RD, Scharf C, Schefer MM, Schegelsky VA, Scheirich D, Schenck F, Schernau M, Scheulen C, Schiavi C, Schioppa EJ, Schioppa M, Schlag B, Schleicher KE, Schlenker S, Schmeing J, Schmidt MA, Schmieden K, Schmitt C, Schmitt N, Schmitt S, Schoeffel L, Schoening A, Scholer PG, Schopf E, Schott M, Schovancova J, Schramm S, Schroeder F, Schroer T, Schultz-Coulon HC, Schumacher M, Schumm BA, Schune P, Schuy AJ, Schwartz HR, Schwartzman A, Schwarz TA, Schwemling P, Schwienhorst R, Sciandra A, Sciolla G, Scuri F, Sebastiani CD, Sedlaczek K, Seema P, Seidel SC, Seiden A, Seidlitz BD, Seitz C, Seixas JM, Sekhniaidze G, Sekula SJ, Selem L, Semprini-Cesari N, Sengupta D, Senthilkumar V, Serin L, Serkin L, Sessa M, Severini H, Sforza F, Sfyrla A, Shabalina E, Shaheen R, Shahinian JD, Shaked Renous D, Shan LY, Shapiro M, Sharma A, Sharma AS, Sharma P, Sharma S, Shatalov PB, Shaw K, Shaw SM, Shcherbakova A, Shen Q, Sheppard DJ, Sherwood P, Shi L, Shi X, Shimmin CO, Shinner JD, Shipsey IPJ, Shirabe S, Shiyakova M, Shlomi J, Shochet MJ, Shojaii J, Shope DR, Shrestha B, Shrestha S, Shrif EM, Shroff MJ, Sicho P, Sickles AM, Sideras Haddad E, Sidoti A, Siegert F, Sijacki D, Sili F, Silva JM, Silva Oliveira MV, Silverstein SB, Simion S, Simoniello R, Simpson EL, Simpson H, Simpson LR, Simpson ND, Simsek S, Sindhu S, Sinervo P, Singh S, Sinha S, Sinha S, Sioli M, Siral I, Sitnikova E, Sivoklokov SY, Sjölin J, Skaf A, Skorda E, Skubic P, Slawinska M, Smakhtin V, Smart BH, Smiesko J, Smirnov SY, Smirnov Y, Smirnova LN, Smirnova O, Smith AC, Smith EA, Smith HA, Smith JL, Smith R, Smizanska M, Smolek K, Snesarev AA, Snider SR, Snoek HL, Snyder S, Sobie R, Soffer A, Solans Sanchez CA, Soldatov EY, Soldevila U, Solodkov AA, Solomon S, Soloshenko A, Solovieva K, Solovyanov OV, Solovyev V, Sommer P, Sonay A, Song WY, Sonneveld JM, Sopczak A, Sopio AL, Sopkova F, Sotarriva Alvarez IR, Sothilingam V, Soto Sandoval OJ, Sottocornola S, Soualah R, Soumaimi Z, South D, Soybelman N, Spagnolo S, Spalla M, Sperlich D, Spigo G, Spinali S, Spiteri DP, Spousta M, Staats EJ, Stabile A, Stamen R, Stampekis A, Standke M, Stanecka E, Stange MV, Stanislaus B, Stanitzki MM, Stapf B, Starchenko EA, Stark GH, Stark J, Starko DM, Staroba P, Starovoitov P, Stärz S, Staszewski R, Stavropoulos G, Steentoft J, Steinberg P, Stelzer B, Stelzer HJ, Stelzer-Chilton O, Stenzel H, Stevenson TJ, Stewart GA, Stewart JR, Stockton MC, Stoicea G, Stolarski M, Stonjek S, Straessner A, Strandberg J, Strandberg S, Stratmann M, Strauss M, Strebler T, Strizenec P, Ströhmer R, Strom DM, Stroynowski R, Strubig A, Stucci SA, Stugu B, Stupak J, Styles NA, Su D, Su S, Su W, Su X, Sugizaki K, Sulin VV, Sullivan MJ, Sultan DMS, Sultanaliyeva L, Sultansoy S, Sumida T, Sun S, Sun S, Gudnadottir OS, Sur N, Sutton MR, Suzuki H, Svatos M, Swiatlowski M, Swirski T, Sykora I, Sykora M, Sykora T, Ta D, Tackmann K, Taffard A, Tafirout R, Tafoya Vargas JS, Takeva EP, Takubo Y, Talby M, Talyshev AA, Tam KC, Tamir NM, Tanaka A, Tanaka J, Tanaka R, Tanasini M, Tao Z, Tapia Araya S, Tapprogge S, Tarek Abouelfadl Mohamed A, Tarem S, Tariq K, Tarna G, Tartarelli GF, Tas P, Tasevsky M, Tassi E, Tate AC, Tateno G, Tayalati Y, Taylor GN, Taylor W, Tee AS, Teixeira De Lima R, Teixeira-Dias P, Teoh JJ, Terashi K, Terron J, Terzo S, Testa M, Teuscher RJ, Thaler A, Theiner O, Themistokleous N, Theveneaux-Pelzer T, Thielmann O, Thomas DW, Thomas JP, Thompson EA, Thompson PD, Thomson E, Tian Y, Tikhomirov V, Tikhonov YA, Timoshenko S, Timoshyn D, Ting EXL, Tipton P, Tlou SH, Tnourji A, Todome K, Todorova-Nova S, Todt S, Togawa M, Tojo J, Tokár S, Tokushuku K, Toldaiev O, Tombs R, Tomoto M, Tompkins L, Topolnicki KW, Torrence E, Torres H, Torró Pastor E, Toscani M, Tosciri C, Tost M, Tovey DR, Traeet A, Trandafir IS, Trefzger T, Tricoli A, Trigger IM, Trincaz-Duvoid S, Trischuk DA, Trocmé B, Troncon C, Truong L, Trzebinski M, Trzupek A, Tsai F, Tsai M, Tsiamis A, Tsiareshka PV, Tsigaridas S, Tsirigotis A, Tsiskaridze V, Tskhadadze EG, Tsopoulou M, Tsujikawa Y, Tsukerman II, Tsulaia V, Tsuno S, Tsuri K, Tsybychev D, Tu Y, Tudorache A, Tudorache V, Tuna AN, Turchikhin S, Turk Cakir I, Turra R, Turtuvshin T, Tuts PM, Tzamarias S, Tzanis P, Tzovara E, Ukegawa F, Ulloa Poblete PA, Umaka EN, Unal G, Unal M, Undrus A, Unel G, Urban J, Urquijo P, Urrejola P, Usai G, Ushioda R, Usman M, Uysal Z, Vacek V, Vachon B, Vadla KOH, Vafeiadis T, Vaitkus A, Valderanis C, Valdes Santurio E, Valente M, Valentinetti S, Valero A, Valiente Moreno E, Vallier A, Valls Ferrer JA, Van Arneman DR, Van Daalen TR, Van Der Graaf A, Van Gemmeren P, Van Rijnbach M, Van Stroud S, Van Vulpen I, Vanadia M, Vandelli W, Vandenbroucke M, Vandewall ER, Vannicola D, Vannoli L, Vari R, Varnes EW, Varni C, Varol T, Varouchas D, Varriale L, Varvell KE, Vasile ME, Vaslin L, Vasquez GA, Vasyukov A, Vazeille F, Vazquez Schroeder T, Veatch J, Vecchio V, Veen MJ, Veliscek I, Veloce LM, Veloso F, Veneziano S, Ventura A, Ventura Gonzalez S, Verbytskyi A, Verducci M, Vergis C, Verissimo De Araujo M, Verkerke W, Vermeulen JC, Vernieri C, Vessella M, Vetterli MC, Vgenopoulos A, Viaux Maira N, Vickey T, Vickey Boeriu OE, Viehhauser GHA, Vigani L, Villa M, Villaplana Perez M, Villhauer EM, Vilucchi E, Vincter MG, Virdee GS, Vishwakarma A, Visibile A, Vittori C, Vivarelli I, Voevodina E, Vogel F, Voigt JC, Vokac P, Volkotrub Y, Von Ahnen J, Von Toerne E, Vormwald B, Vorobel V, Vorobev K, Vos M, Voss K, Vossebeld JH, Vozak M, Vozdecky L, Vranjes N, Vranjes Milosavljevic M, Vreeswijk M, Vuillermet R, Vujinovic O, Vukotic I, Wada S, Wagner C, Wagner JM, Wagner W, Wahdan S, Wahlberg H, Wakida M, Walder J, Walker R, Walkowiak W, Wall A, Wamorkar T, Wang AZ, Wang C, Wang C, Wang H, Wang J, Wang RJ, Wang R, Wang R, Wang SM, Wang S, Wang T, Wang WT, Wang W, Wang X, Wang X, Wang X, Wang Y, Wang Y, Wang Z, Wang Z, Wang Z, Warburton A, Ward RJ, Warrack N, Watson AT, Watson H, Watson MF, Watton E, Watts G, Waugh BM, Weber C, Weber HA, Weber MS, Weber SM, Wei C, Wei Y, Weidberg AR, Weik EJ, Weingarten J, Weirich M, Weiser C, Wells CJ, Wenaus T, Wendland B, Wengler T, Wenke NS, Wermes N, Wessels M, Wharton AM, White AS, White A, White MJ, Whiteson D, Wickremasinghe L, Wiedenmann W, Wiel C, Wielers M, Wiglesworth C, Wilbern DJ, Wilkens HG, Williams DM, Williams HH, Williams S, Willocq S, Wilson BJ, Windischhofer PJ, Winkel FI, Winklmeier F, Winter BT, Winter JK, Wittgen M, Wobisch M, Wolffs Z, Wollrath J, Wolter MW, Wolters H, Wongel AF, Woodward EL, Worm SD, Wosiek BK, Woźniak KW, Wozniewski S, Wraight K, Wu C, Wu J, Wu M, Wu M, Wu SL, Wu X, Wu Y, Wu Z, Wuerzinger J, Wyatt TR, Wynne BM, Xella S, Xia L, Xia M, Xiang J, Xie M, Xie X, Xin S, Xiong A, Xiong J, Xu D, Xu H, Xu L, Xu R, Xu T, Xu Y, Xu Z, Xu Z, Yabsley B, Yacoob S, Yamaguchi Y, Yamashita E, Yamauchi H, Yamazaki T, Yamazaki Y, Yan J, Yan S, Yan Z, Yang HJ, Yang HT, Yang S, Yang T, Yang X, Yang X, Yang Y, Yang Y, Yang Z, Yao WM, Yap YC, Ye H, Ye H, Ye J, Ye S, Ye X, Yeh Y, Yeletskikh I, Yeo BK, Yexley MR, Yin P, Yorita K, Younas S, Young CJS, Young C, Yu C, Yu Y, Yuan M, Yuan R, Yue L, Zaazoua M, Zabinski B, Zaid E, Zak ZK, Zakareishvili T, Zakharchuk N, Zambito S, Zamora Saa JA, Zang J, Zanzi D, Zaplatilek O, Zeitnitz C, Zeng H, Zeng JC, Zenger DT, Zenin O, Ženiš T, Zenz S, Zerradi S, Zerwas D, Zhai M, Zhang B, Zhang DF, Zhang J, Zhang J, Zhang K, Zhang L, Zhang P, Zhang R, Zhang S, Zhang S, Zhang T, Zhang X, Zhang X, Zhang Y, Zhang Y, Zhang Y, Zhang Z, Zhang Z, Zhao H, Zhao T, Zhao Y, Zhao Z, Zhemchugov A, Zheng J, Zheng K, Zheng X, Zheng Z, Zhong D, Zhou B, Zhou H, Zhou N, Zhou Y, Zhu CG, Zhu J, Zhu Y, Zhu Y, Zhuang X, Zhukov K, Zhulanov V, Zimine NI, Zinsser J, Ziolkowski M, Živković L, Zoccoli A, Zoch K, Zorbas TG, Zormpa O, Zou W, Zwalinski L. Azimuthal Angle Correlations of Muons Produced via Heavy-Flavor Decays in 5.02 TeV Pb+Pb and pp Collisions with the ATLAS Detector. PHYSICAL REVIEW LETTERS 2024; 132:202301. [PMID: 38829073 DOI: 10.1103/physrevlett.132.202301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Accepted: 03/13/2024] [Indexed: 06/05/2024]
Abstract
Angular correlations between heavy quarks provide a unique probe of the quark-gluon plasma created in ultrarelativistic heavy-ion collisions. Results are presented of a measurement of the azimuthal angle correlations between muons originating from semileptonic decays of heavy quarks produced in 5.02 TeV Pb+Pb and pp collisions at the LHC. The muons are measured with transverse momenta and pseudorapidities satisfying p_{T}^{μ}>4 GeV and |η^{μ}|<2.4, respectively. The distributions of azimuthal angle separation Δϕ for muon pairs having pseudorapidity separation |Δη|>0.8, are measured in different Pb+Pb centrality intervals and compared to the same distribution measured in pp collisions at the same center-of-mass energy. Results are presented separately for muon pairs with opposite-sign charges, same-sign charges, and all pairs. A clear peak is observed in all Δϕ distributions at Δϕ∼π, consistent with the parent heavy-quark pairs being produced via hard-scattering processes. The widths of that peak, characterized using Cauchy-Lorentz fits to the Δϕ distributions, are found to not vary significantly as a function of Pb+Pb collision centrality and are similar for pp and Pb+Pb collisions. This observation will provide important constraints on theoretical descriptions of heavy-quark interactions with the quark-gluon plasma.
Collapse
|
50
|
Guo J, Fei XS, Zhang X, Lin FS. [A case of hematogenous disseminated tuberculosis in a patient with contradictory reactions treated with thalidomide]. ZHONGHUA JIE HE HE HU XI ZA ZHI = ZHONGHUA JIEHE HE HUXI ZAZHI = CHINESE JOURNAL OF TUBERCULOSIS AND RESPIRATORY DISEASES 2024; 47:455-459. [PMID: 38706068 DOI: 10.3760/cma.j.cn112147-20231014-00231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/07/2024]
Abstract
Here we reported a case of a 52-year-old male with a 13-year history of Crohn's disease who developed disseminated tuberculosis after 2 injections of infliximab. The patient was admitted with a chief complaint of fever with headache of 1 month's duration. Mycobacterium tuberculosis DNA was found positive in cerebrospinal fluid and lavage fluid by lumbar puncture and bronchoscopy. He was diagnosed with tuberculous meningitis, pulmonary tuberculosis, tracheobronchial tuberculosis and lymph node tuberculosis. After treatment with anti-tuberculosis and glucocorticoids, the symptoms did not improve, the lesions progressed, and granulomas were formed in the tracheobronchial lumen. These were considered to be contradictory reactions and thalidomide was given together with glucocorticoids. The patient's clinical condition has improved significantly. Treatment was successfully completed after 18 months with 1 HREZLfxLzd/8 HEZCsLzd/1 HEZCs/8 HZCs.
Collapse
|